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Cancer impacts millions of people in the United States.  Understanding the 
precursors to cancer is important for prevention efforts.  The purpose of this study was to 
investigate potential relationships between sleep, allostatic load, and future cancer 
occurrence.  A conceptual framework of responses to stress adapted from a model for 
allostatic load was used to guide this investigation.  The framework depicts cognitive-
behavioral responses to stress and physiologic responses to stress impacting future 
disease occurrence.  Subjective sleep quality and sleep duration (cognitive-behavioral 
responses to stress) and allostatic load (physiologic response to stress) were suspected of 
having an impact on future cancer occurrence.  
Secondary data analysis of longitudinal data from the Midlife in the United States 
study of middle aged and older adults in the United States was employed to explore a 
relationship between sleep and future cancer occurrence, a relationship between allostatic 
load and future cancer occurrence, a relationship between sleep and allostatic load, and 
lastly, a possible mediating role for allostatic load in the sleep – future cancer occurrence 
relationship A nationally representative sample of 806 persons with oversampling for 
men, older adults, and African Americans was used for analysis. 
Sleep parameters were measured by the Pittsburgh Sleep Quality Index (PSQI), a 
scale with 21 items in seven domains.  Overall subjective sleep quality and the seven 
sleep were analyzed in relation to future cancer occurrence and in relation to allostatic 
load.  In addition to the variable for sleep duration found in the PSQI, continuous hours 
 
of sleep, categorical sleep duration based on National Sleep Foundation 
recommendations, and categorical sleep duration derived from the actual data were 
analyzed in relation to future cancer occurrence and in relation to allostatic load.  
Allostatic load was comprised of 23 individual measures across seven physiologic 
domains compiled using a validated bifactor model.  Overall allostatic load and the seven 
physiologic domains were analyzed in relation to future cancer occurrence.  Statistical 
models included individual differences (age, race, gender, education, and income) and 
other cognitive-behavioral responses to stress (smoking, alcohol use, physical activity, 
and depression) thought to be related to the three main concepts of interest (sleep, 
allostatic load, and future cancer occurrence).   
Of the permutations of sleep duration, categorical sleep derived from the data fit 
the best.  Short sleep duration (<5.3 hours per night) was associated with a 4.5 times 
increase in the odds of future cancer and long sleep duration (>7.5 hours per night) was 
associated with a 2.2 times increase in the odds of future cancer when compared to the 
referent sleep duration category (5.3-7.5 hours per night).  Age was the only other 
measure to show a relationship with future cancer; each increasing year of age was 
associated with a 3% increase in the odds of future cancer occurrence.   
Poor subjective sleep quality was associated with increased allostatic load. Poor 
subjective sleep quality was associated with decreased hypothalamic-pituitary-adrenal 
axis domain scores.  No relationship was found between subjective sleep quality or the 
seven sleep domains and future cancer occurrence.  No relationship was found between 
allostatic load or the seven physiologic domains and future cancer occurrence.  No 
 
relationship was found between sleep duration and allostatic load.  Finally, allostatic load 
did not play a mediating role in the sleep – future cancer occurrence relationship. 
This analysis demonstrates that sleep is an important facet of health, and should 
be routinely assessed by Advanced Practice Registered Nurses as a part of health 
maintenance and guidance about sleep should be offered to adults.  In nursing education, 
sleep problems should be emphasized as a risk factor for health problems.  
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CHAPTER I 
 INTRODUCTION 
                                                                                                                                                    
 
Prevention of cancer is an important role for health professionals due to the 
continued incidence, mortality, quality of life, and health care costs.  Traditional 
prevention efforts have included health behavior change, reducing environmental 
exposure to toxins, and identifying high risk demographic groups and geographic areas. 
More recently, genetic marker tests for several cancer types indicate lifelong risk.  
However, existing research does not indicate how specific responses to stress are 
associated with future cancer occurrence.  The need is for investigation of how responses 
to stress over time may result in cancer.  Two important areas to explore are cognitive-
behavioral responses to stress and physiologic responses to stress as precursors to cancer.    
Sleep is known to be important for health, but why humans sleep and the 
cognitive and physiologic changes humans undergo during sleep and still being explored 
(Harvard Medical School, Division of Sleep Medicine, 2007).  There is no accepted 
medical definition of sleep and sleep researchers define sleep by its characteristics 
(Harvard Medical School, Division of Sleep Medicine, 2007).  Sleep is differentiated 
from wakefulness by changes in consciousness and physiologic functions (Harvard 
Medical School, Division of Sleep Medicine, 2007).  Sleep is both an involuntary action, 
such as breathing, as well as a behavior able to impacted by individual experiences 
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(Perry, Patil, & Presley-Cantrell, 2013).  This study considered sleep to be a cognitive-
behavioral response to stress.  Sleep as a precursor to cancer is understudied.   
Allostasis is the mechanism by which the body adapts to internal and external 
stimuli and allows the body to continue healthy functioning.  Allostasis is a mechanism 
for maintaining life.  Allostatic load is defined as “the wear and tear on the body and 
brain resulting from chronic overactivity or inactivity of physiological systems that are 
normally involved in adaptation to environmental challenge” (McEwen, 1998b, p. 37).  
Conceptually, allostasis is the body’s adaptation to challenges in the short term that 
maintain life.  Allostatic load is the long-term consequence of allostasis. This study 
considered allostatic load to be a physiologic response to stress. 
 This study examined potential links between sleep, allostatic load, and future 
cancer occurrence.  Existing evidence was used to build rationale for the study.  When 
limited evidence was found amongst sleep, allostatic load, and future cancer, the review 
of the literature was expanded to include existing cancer.   
Cancer 
Cancer is a disease “characterized by uncontrolled growth and spread of abnormal 
cells” (National Cancer Institute, n.d.-d).  Cancer is an ancient disease, with the first 
documentation of cancer estimated to be from around 2500 B.C. (National Cancer 
Institute, n.d.-a).  Historically, cancer was considered a fatal disease, and over the last 
century, cancer deaths have increased substantially.  In 1900 in the United States (US), 
the annual rate of cancer deaths was 64 per 100,000 people (Silverberg & Holleb, 1972).  
By 1968, the mortality rate for cancer was 159 deaths per 100,000 people (Silverberg & 
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Holleb, 1972).  The mortality rate for cancer peaked in 1999 at 215.1 deaths per 100,000 
people and by 2014, the mortality rate for cancer had declined to 166.1 (National Cancer 
Institute, n.d.-c).  In 2017, NCI estimates there will be over 600,000 deaths from cancer 
(National Cancer Institute, n.d.-b).   
Persons with cancer comprise a large segment of the population.  In 2017, it was 
estimated that 1,688,780 persons in the United States were diagnosed with a new cancer 
(National Cancer Institute, n.d.-c).  With improvements in screening for cancer and 
cancer treatment, there were an estimated 15.5 million cancer survivors in the United 
States in 2016, and this number is projected to increase to 26 million by 2040 
(Bluethmann, Mariotto, & Rowland, 2016).  By any metric, cancer has considerable 
impact on United States citizens.  Advances in treatment modalities for cancer are an 
important area of study, but research examining cancer causes, with the goal of cancer 
prevention, needs significant attention.  Although many factors believed to be associated 
with carcinogenesis have been identified, understanding the causal pathways leading to 
cancer formation requires further investigation.  Two important areas needing 
investigation are cognitive-behavioral responses to stress and physiologic responses to 
stress as precursors to cancer.    
Sleep 
 Sleep has been shown to be vital for good health (Buysse, 2014; Irwin, Witarama, 
Caudill, Olmstead, & Breen, 2015).  Sleep is both an involuntary action, such as 
breathing, as well as a behavior able to impacted by individual experiences (Perry et al., 
2013).  The Centers for Disease Control and Prevention (CDC) reports that insufficient 
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sleep is associated with chronic diseases and injuries (Centers for Disease Control and 
Prevention, 2017a).  Objective sleep measures can be useful in assessing sleep and in 
diagnosing sleep problems like sleep apnea, but subjective measures are important to 
consider. The diagnosis of insomnia is made from subjective sleep information alone 
(American Psychiatric Association, 2013; Irwin et al., 2015).  There is no single 
definition of healthy sleep.  However, there is some consensus on a few parameters of 
healthy sleep.  For example, the National Sleep Foundation (NSF) established 
recommended sleep duration by age (Hirshkowitz et al., 2015a).  NSF recommends most 
adults ages 18-64 get between 7 and 9 hours a sleep per day and adults 65 and older get 
between 7 to 8 hours of sleep per night (Hirshkowitz et al., 2015a).  Some adults ages 18-
64 may need as few as 6 hours or as many as 10 hours of sleep per night (Hirshkowitz et 
al., 2015a).  Other indicators of healthy sleep include sleep efficiency (defined as the 
ratio of time asleep to time in bed), sleep latency (defined as the amount of time it takes 
to fall asleep), and awakenings or disturbances (defined as the number of occurrences of 
wakefulness lasting more than 5 minutes) (Ohayon et al., 2017).  The ranges of each 
indicator vary by age and by sex.  In addition, sleep requirements can vary at the 
individual level by season, geographic latitude, and by life schedule such as work or 
school (Ohayon et al., 2017).  In short, sleep is an important, necessary component of 
health, but the parameters of healthy sleep can vary widely on the individual level.   
Sleep problems are common in the United States, and sleep duration is a 
frequently studied sleep parameter.  Too little sleep and too much sleep are both 
considered to be concerning (American Psychiatric Association, 2013).  In 2014, the 
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prevalence of short sleep duration (defined as <7 hours per day) among adults ranged 
from 26-39% depending on age group (Centers for Disease Control and Prevention, 
2017b).  The prevalence of long sleep duration (defined as >9 hours per day) was 37% 
among all adults in 2007 (Bin, Marshall, & Glozier, 2013).  Sleep duration has shown 
significant variation is different populations.  People who are obese, those who are 
physically inactive, and those who smoke are more likely to report having a short sleep 
duration (Centers for Disease Control and Prevention, 2017b).  By race and ethnicity, 
white Americans are less likely to report having a short sleep duration compared to any 
other group (Centers for Disease Control and Prevention, 2017b). Native 
Hawaiians/Pacific Islanders (46%) and black Americans (46%) are the groups with the 
greatest prevalence of short sleep duration is (Centers for Disease Control and 
Prevention, 2017b).   
Sleep problems as precursors to poor health outcomes are increasingly being 
studied.  Short sleep duration has been linked to obesity, diabetes, elevated blood 
pressure, and all-cause mortality risk (Cappuccio et al., 2008; Cappuccio, D’Elia, 
Strazzullo, & Miller, 2010; Cappucio, D’Elia, Strazzullo, & Miller, 2010; Ju & Choi, 
2013; Knutson et al., 2009).  Outside of sleep duration, other parameters of sleep have 
been less studied.  There is limited evidence that self-reported sleep quality is associated 
with health outcomes.  A large prospective study of over 50,000 men and women in 
Norway found that self-reported problems initiating sleep, maintaining sleep, and 
experiencing nonrestorative sleep are associated with an increase of risk of future 
myocardial infarction (Laugsand, Vatten, Platou, & Janszky, 2011).  A study of adults in 
 
 
 
6 
the United Kingdom found self-reported good sleep quality was associated with better 
mental and physical health (Gadie, Shafto, Leng, Cam-CAN, & Kievit, 2017). In 
contrast, a large prospective study of over 14,000 men and women in Japan found no 
relationship between sleep quality and risk of mortality from cardiovascular disease 
(Suzuki et al., 2009).   
Cancer and Sleep 
Sleep is widely known to be a problem for patients with existing cancer 
diagnoses, but prevalence and causes are not firmly established (Otte et al., 2015).  
Subjective sleep quality is a commonly studied sleep parameter in individuals with 
cancer, and there is limited information on sleep duration for persons living with cancer.  
Sleep quality has been shown to be a problem for people diagnosed with cancer before, 
during and after treatment (Ancoli-Israel et al., 2006; Lauren Clevenger et al., 2012; L. 
Liu et al., 2012; Tian, Chen, & Zhang, 2015).  In addition, there is some information on 
sleep in cancer survivors, with one-third of cancer survivors experiencing shorter sleep 
duration or sleep disturbance lasting four or more years after diagnosis (Bardwell et al., 
2008; Klyushnenkova, Sorkin, & Gallicchio, 2015).   
As with other research into sleep as a potential risk factor for disease processes, 
interest in sleep problems as risk factors for future cancer occurrence has increased.  
Sleep duration is the most studied parameter for this area although the evidence is scant.  
Studies of sleep duration have not found a link between sleep duration and incidence of 
breast cancer, however, there is evidence demonstrating that shorter sleep duration may 
be associated with more aggressive breast cancer type (Qin, Zhou, Zhang, Wei, & He, 
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2014; Soucise et al., 2017; Thompson & Li, 2012; Wong et al., 2017).  The evidence for 
sleep problems as a risk factor for other cancers is mixed.  Some studies of sleep duration 
have reported sleep duration is associated with an increased risk of future colon cancer 
occurrence, while other researchers have found no link between colon cancer risk and 
sleep duration (Devore et al., 2017; Jiao et al., 2013; Thompson et al., 2011).  A 
prospective study of Finnish men found an increase in lung cancer incidence related to 
sleep duration (Luojus, Lehto, Tolmunen, Erkkilä, & Kauhanen, 2014).  A study of rural 
Chinese citizens over the life course showed men over 41 years of age had an increased 
risk of lung cancer mortality associated with sleep duration, (Wong et al., 2017).  Among 
Chinese women, short sleep duration was associated with an increased risk of lung cancer 
mortality for ages 51 and older; long sleep duration was associated with an increased risk 
of lung cancer in women 60 and younger (Wong et al., 2017). 
Other sleep parameters, such as sleep quality, in relation to future cancer risk have 
been even less studied.  Self-reported average or poor sleep quality has been found to be 
associated with more aggressive breast cancer among African-American women (Soucise 
et al., 2017).  Self-reported sleep problems of difficulty falling asleep and difficulty 
staying asleep were associated with an increased risk of prostate cancer 3 to 7 years later 
(Sigurdardottir et al., 2013).  In a retrospective study using Taiwan’s National Health 
Insurance Research Database (which covers 98% of Taiwan’s population), Fang et al 
(2015) found an increased risk of breast cancer, nasal cancer, liver cancer, cervical 
cancer, oral cancer colon cancer lymphatic cancer, thyroid cancer, myeloma, prostate 
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cancer, bladder cancer, kidney cancer and other cancers among those with a diagnosis of 
insomnia at least 2 years prior to cancer diagnosis.   
The relationship between sleep problems and people with cancer is well known, 
even though the prevalence and causal pathways have yet to be specified.  The role of 
sleep in carcinogenesis, however, has received little attention.  Although the evidence is 
scant, there are indications that sleep parameters, such as sleep duration and subjective 
sleep quality, may play a role in carcinogenesis.  Longitudinal studies are needed to 
establish a link between sleep and future cancer occurrence. 
Allostatic Load 
The term allostasis was coined by Sterling and Eyer in 1988 and is defined as “the 
operating range, and the ability of the body to increase or decrease vital functions to a 
new steady state on challenge” (McEwen & Stellar, 1993, p. 2094).  Allostasis is the 
mechanism by which the body adapts to stressors and allows the body to continue 
functioning.  Allostasis is distinct from homeostasis.  The principle of homeostasis 
reflects the idea that the body, in response to some physiologic disruption, will work to 
return to a rigid, unchanging set point (McEwen & Wingfield, 2010).   In contrast, 
allostasis specifies that in the face of changes in physiologic condition, the body will 
respond to challenges to return to flexible, adaptable set points (McEwen & Wingfield, 
2010).  For example, when a person undergoes the stress of rapidly change from a sitting 
to a standing position, the body alters the blood pressure and heart rate to prevent 
syncope.  In this example, the principle of homeostasis requires blood pressure and heart 
rate to return to narrowly defined, unchanging “normal” set points.  Allostasis, on the 
 
 
 
9 
other hand, allows for the body to adapt to new “normal” set points for blood pressure 
and heart rate based on internal and external environmental circumstances to prevent 
syncope.  Allostasis is a mechanism for maintaining health.  Several years after the 
concept of allostasis was developed, the term allostatic load was coined by McEwen and 
Stellar (1993) to describe the overuse or abnormal performance of the body’s systems of 
allostasis that can accumulate over time and lead to disease.  Conceptually, allostasis is 
the body’s adaptation to challenges in the short term that maintain life.  Allostatic load is 
the long-term consequence of allostasis.  Allostatic load is defined as “the wear and tear 
on the body and brain resulting from chronic over-activity or inactivity of physiological 
systems that are normally involved in adaptation to environmental challenge” (McEwen, 
1998b, p. 37).  In other words, adapting to stressors to maintain the body “has a price, and 
we have come to define the cost of adaptation as allostatic load” (McEwen, 1998b, p. 37).  
Ten years after allostatic load was defined, the term allostatic overload began to appear in 
the literature, and is defined as the point at which allostatic load becomes critical and 
leads to serious pathology (McEwen & Wingfield, 2003).  Allostatic load and allostatic 
overload differ in that allostatic load represents the accumulation of the effects of 
allostasis over time, and allostatic overload reflects the point at which this accumulation 
becomes pathological.  As the point at which allostatic load becomes allostatic overload 
is not established for cancer, this study uses allostatic load as a concept.   
Since the concept of allostatic load was conceived, it has been operationally 
defined and used in research in a variety of ways.  In general, allostatic load has been 
studied by measuring a variety of biomarkers of various physiological processes in an 
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attempt to examine physiological dysfunction in multiple systems and the impact on 
health.  One of the earliest studies using allostatic load was a study of aging (T. E. 
Seeman, Singer, Rowe, Horwitz, & McEwen, 1997).  This study measured systolic and 
diastolic blood pressure, waist-hip ratio, serum high-density lipoprotein (HDL), serum 
total cholesterol, serum glycosylated hemoglobin (HbA1c), serum 
dehydroepiandrosterone sulfate (DHEAS), 12-hour urinary cortisol, and 12-hour urinary 
norepinephrine and epinephrine.  Each of these 10 biomarkers was then categorized into 
quartiles of risk based on the distribution of results from the healthiest participants (T. E. 
Seeman et al., 1997).  A participant’s allostatic load score was then calculated by 
summing those biomarkers that fell into the highest quartile of risk (T. E. Seeman et al., 
1997).   
In the twenty years since the publication of this study, operationalization of 
allostatic load has evolved and been adapted depending on the hypotheses about the 
outcomes of a particular study.  New methods continue to emerge.  Allostatic load 
measures can be comprised of neuroendocrine biomarkers (such as cortisol, DHEAS, 
epinephrine and dopamine), immune biomarkers (such as interleukin-6, C-reactive 
protein, and insulin-like growth factor-1), metabolic biomarkers (such as HDL, HbA1c, 
and creatinine), cardiovascular biomarkers (such as systolic blood pressure and heart 
rate), respiratory biomarkers (such as peak expiratory flow), and anthropomorphic 
biomarkers (such as waist-hip ratio) (Juster, McEwen, & Lupien, 2010).  The biomarkers 
comprising allostatic load in a particular study vary based on the hypothesized 
mechanism of the relationships between concepts and outcomes of interest.   
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Traditionally, allostatic load was treated as a composite of biomarkers with high 
risk values (Juster et al., 2010).  High risk values for biomarkers were identified either by 
analyzing the distribution of results from study subjects or by using a priori identified 
clinically meaningful values (Juster et al., 2010).  Recent publications have used case-
based computational modeling and structural equation modeling for analysis (Galen 
Buckwalter et al., 2016; Wiley, Gruenewald, Karlamangla, & Seeman, 2016).  Regardless 
of the measure or calculation, higher levels of allostatic load indicate higher levels of 
physiologic dysfunction. Although research into allostatic load is emerging, there is 
evidence linking allostatic load to all-cause mortality, physical functioning, cognitive 
functioning, hypertension, diabetes, and cardiovascular disease (Judith E. Carroll, Irwin, 
Merkin, & Seeman, 2015; X. Chen, Redline, Shields, Williams, & Williams, 2014; Clark 
et al., 2014). 
Cancer and Allostatic Load 
The relationship between cancer and allostatic load is unclear from current 
evidence. In fact, only one study was identified that examined cancer issues in relation to 
allostatic load as an indicator of multisystem dysfunction.  In this study of breast cancer 
disparities between black and white women, black women with breast cancer were found 
to have elevated allostatic load, but this was not true among white women (Parente, Hale, 
& Palermo, 2013).  No research was identified that examined allostatic load in 
relationship to future cancer occurrence.   
While the evidence linking allostatic load to cancer is rare, some studies have 
investigated the relationship between cancer and individual biomarkers thought to 
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comprise allostatic load.  Research has demonstrated links between cortisol, insulin 
growth factor-1, intercellular adhesion molecule-1, and interleukin-6 and patients with 
cancer (Mazzoccoli et al., 2003; Mills et al., 2008; Schrepf et al., 2015; S. E. Sephton et 
al., 2013; S. Sephton, Sapolsky, Kraemer, & Spiegel, 2000; Wang et al., 2010).  Only one 
study was identified that investigated biomarkers as predictors of future cancer 
occurrence, reporting that high blood glucose was associated with an increased risk in 
breast cancer up to 15 years later (Agnoli et al., 2015).   
Sleep and Allostatic Load 
There have been a small number of studies investigating the relationship between 
sleep and allostatic load.  Sleep duration is the most commonly studied sleep parameter.  
Studies of sleep duration and allostatic load have shown mixed results.  Some reports 
indicate sleep duration are associated with increased allostatic load; others studies have 
not identified this relationship (Judith E. Carroll et al., 2015; X. Chen et al., 2014; Clark 
et al., 2014).  Allostatic load has been examined in relation to sleep disorders.  The 
prevalence of increased average allostatic load was found to be high among adults with 
sleep apnea, snoring, snorting/stop breathing, insomnia and diagnosed sleep disorders 
compared with persons without these sleep disturbances (X. Chen et al., 2014).  Very 
little research has been devoted to relationships between subjective sleep quality and 
allostatic load in cancer patients or in any population.    
Overall, the concept of allostatic load is nascent, and consequently there is a need 
for future research into factors associated with allostatic load and into connections 
between allostatic load and health outcomes.  Cancer in particular has been neglected by 
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researchers of allostatic load.  Longitudinal studies of allostatic load and future cancer 
occurrence would illuminate whether a relationship exists between the two and provide 
areas for prevention.  Additionally, there are no studies investigating all three concepts of 
allostatic load, sleep parameters, and future cancer occurrence.   
Purpose of the Study 
 Understanding the factors that can lead to cancer occurrence will help guide 
cancer prevention efforts.  Healthy sleep is required for good health (Centers for Disease 
Control and Prevention, 2017a; National Sleep Foundation, 2017).  Although sleep 
problems have been implicated in morbidity and mortality outcomes, little study has been 
devoted to investigating the potential role poor sleep could play in carcinogenesis.  This 
study investigated the potential relationship between sleep problems and future cancer 
occurrence.  Allostatic load is an important concept that seeks to explain the processes by 
which daily life occurrences and major life events are manifested in the body 
physiologically. There is evidence that allostatic load is associated with morbidity and 
mortality, but no research has yet been devoted to investigating the role of allostatic load 
in future cancers.  This study investigated the potential relationship between allostatic 
load and future cancer occurrences.  Lastly, the potential mediating role allostatic load 
may play in the pathway between sleep problems and cancer incidence was explored.   
Conceptual Framework 
There is at present no theory connecting sleep, allostatic load, and cancer.  
However, the conceptual model of allostatic load can be adapted to encompass the 
aspects of this proposed study (McEwen, 1998a, p. 172).  The revised model shows 
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individual differences influencing cognitive-behavioral responses to stress and 
physiologic responses to stress, and cognitive-behavioral responses to stress impacting 
physiologic responses to stress.  The model then shows relationships between cognitive-
behavioral responses and disease occurrence and between physiological responses and 
disease occurrence.   
This study defines stress as the individual experience of everyday life stress and 
stressful life events.  The American Psychological Association surveys Americans about 
stress annually.  In 2017, American’s average reported stress level was 5.1 on a 10 point 
scale (ranging from “very little stress” (1) to “a great deal of stress” (10)) (American 
Psychological Association, 2017, p. 1).  Additionally, 80% of respondents reported 
experiencing at least one physical or emotional symptom of stress in the past month, 
while 20% of respondents rated their experience of stress as “extreme” (American 
Psychological Association, 2017).  In short, it is a safe assumption that all humans 
experience stress in their lives.  The focus of this study is not to measure stress, but 
response to stress and the impact on cancer occurrence.   
The concepts in the model key to the purpose of this study were cognitive-
behavioral responses to stress, physiologic responses to stress, individual differences, and 
disease.  This study defined cognitive-behavioral responses to stress as thoughts, 
reasoning, feelings, and actions in response to stimuli.  Sleep was the primary cognitive-
behavioral response to stress in this proposed study.  Additional cognitive-behavioral 
responses to stress included sleep, health behaviors (alcohol use, smoking, physical 
activity), and depressive symptoms.  Physiologic responses to stress were defined as the 
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biologic embodiment of reaction to stimuli and the primary physiologic response to stress 
in this proposed study is allostatic load.  Allostatic load encompasses biomarkers from 
specific physiologic domains.  The conceptual framework shows both cognitive-
behavioral and physiologic responses to stress as influencing disease occurrence.  Disease 
was defined as a change from normal functioning that causes harm and in this study was 
considered cancer.  Individual differences were defined as personal characteristics that 
may result in variations in disease. Examples of individual differences included in this 
study were age, race, gender, education and income. The model depicts individual 
differences as impacting physiologic responses to stress and impacting cognitive-
behavioral responses to stress via stress.   
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Figure 1 
Model of Responses to Stress 
Adapted from Bruce S. McEwen (1998a, p. 172).  
 
Definitions of Major Concepts 
 
1. Cancer was defined as uncontrolled growth and spread of abnormal cells (National  
 
Cancer Institute, n.d.-c). Cancer is a disease and was operationalized as future cancer  
 
occurrence.  
2. Sleep was defined as “the natural periodic suspension of consciousness during which 
the powers of the body are restored” (Merriam-Webster, 2017).  Sleep is differentiated 
from wakefulness by changes in consciousness and physiologic functions (Harvard 
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Medical School, Division of Sleep Medicine, 2007).  Sleep is both an involuntary action, 
such as breathing, as well as a behavior able to impacted by individual experiences (Perry 
et al., 2013).  Sleep is a cognitive-behavioral response to stress. For this study, sleep was 
operationalized as sleep duration and subjective sleep quality.  
3. Other cognitive-behavioral responses to stress 
 A. Health behaviors 
i. Physical activity was defined as participation in active leisure-time  
activities that result in raised heart rate and sweating. 
ii. Alcohol use was defined as the consumption of alcohol containing  
beverages 
iii. Smoking history was defined as use of cigarettes at present or in the  
past 
B. Depressive symptoms were self-reported complaints of symptoms commonly 
associated with depression including “depressed mood, feelings of guilt and 
worthlessness, feelings of helplessness and hopelessness, psychomotor 
retardation, loss of appetite and sleep disturbance” (Radloff, 1977, p. 386) 
4. Allostatic load was defined as “the wear and tear on the body and brain resulting from 
chronic overactivity or inactivity of physiological systems that are normally involved in 
adaptation to environmental challenge” (McEwen, 1998b, p. 37).  Allostatic load was a 
physiologic response to stress. This was operationalized through biomarkers, physical 
measures, and psychophysiologic measures from specific physiologic domains.  
Physiologic domain biomarkers included sympathetic nervous system hormones, 
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hypothalamic-pituitary-adrenal axis hormones, serum endocrine system measures, 
inflammatory markers, and cholesterol measures.  Physical measures included measures 
of the cardiovascular system and obesity.  Psychophysiologic measures included    
parasympathetic nervous system indicators.  
5. Individual differences were personal characteristics that may reflect variation in 
responses to stress.  Several indicators were used to determine this variation in response.  
A. Age is a demographic measure defined as the length of a person’s life in years 
and was operationalized as years of age 
B. Gender is a demographic measure defined as behavioral cultural or 
psychological traits typically associated with one particular sex.  In this study, 
there were two self-reported genders, female and male.   
C. Race is demographic measure defined as a categorization of humans based on 
select physical characteristics, typically skin color.  In this study, race was 
operationalized at white or not white.  
D. Education is a socioeconomic measure defined as the highest type of formal 
learning program completed 
E. Income is a sociodemographic measure defined as amount of incoming 
financial resources (whether in dollars or some kind of government assistance) for 
respondent’s household in the year of study.  
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Research Questions 
 The following questions were examined in this study:  
1. Research Question 1. Is there a relationship between sleep and future cancer 
occurrence among middle-aged adults in the United States? 
 Hypothesis 1.1: Poor self-reported, subjective sleep quality will be associated 
with increased future cancer occurrence.  
 Hypothesis 1.2: Short sleep duration and long sleep duration as compared to 
normal/healthy sleep duration will be associated with increased future cancer occurrence.  
2. Research Question 2.  Is there a relationship between allostatic load and occurrence of 
future cancers among middle-aged adults in the United States.? If there is, are there 
physiologic domains that are associated with the occurrence of future cancers? 
 Hypothesis 2.1: Increased allostatic load will be associated with increased 
occurrence of future cancers.   
 Hypothesis 2.2: The inflammation domain, sympathetic nervous system domain, 
and hypothalamic-pituitary-adrenal axis domain will be associated with the occurrence of 
future cancers.   
3. Research Question 3. Is there a relationship between sleep and allostatic load among 
middle-aged adults in the United States? If a relationship exists, are there physiologic 
domains that are associated with sleep?   
 Hypothesis 3.1: Poor self-reported, subjective sleep quality will be associated 
with increased allostatic load.  
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 Hypothesis 3.2: Short sleep duration and long sleep duration as compared to 
normal/healthy sleep duration will be associated with increased allostatic load.  
 Hypothesis 3.3:  Poor sleep will be associated with the inflammation domain, 
glucose domain, lipid domain, and cardiovascular domain.   
4. Research Question 4. If a relationship exists between sleep and the occurrence of 
future cancers among middle-aged adults, does allostatic load mediate that relationship?  
 Hypothesis 4.1: Allostatic load will mediate the sleep-future cancer occurrence 
relationship.  
Summary 
 Prevention of cancer and its consequences is an important role for health care 
professionals.  Cancer impacts millions of Americans; there are an estimated 15.5 million 
people living with cancer in the US, and this number is expected to increase substantially 
over the next 20-25 years (Bluethmann et al., 2016).  While prompt diagnosis and 
treatment are key to cancer survival, understanding the precursors of carcinogenesis is 
important for disease prevention efforts.  Two underexplored areas of interest are 
cognitive-behavioral responses to stress and physiologic responses to stress.  Prior scant 
research into sleep, a cognitive-behavioral response to stress, indicates sleep may have a 
relationship with cancer occurrence.  There is very limited research examining the links 
between allostatic load, a physiologic response to stress, and cancer.  This study 
examined potential associations between sleep, allostatic load, and future cancer 
occurrence to help address this gap.   
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CHAPTER II 
 LITERATURE REVIEW 
Introduction 
 This examination of the literature reviewed the available evidence related to 
cancer occurrence and sleep, a cognitive-behavioral response to stress, and allostatic load, 
a physiologic response to stress.  As depicted in the conceptual framework shown in 
Figure 1, it was suspected that sleep and allostatic load are related to future cancer.  
Further, it was suspected that allostatic load may mediate the sleep-future cancer 
relationship.  The available knowledge regarding cancer and sleep, cancer and allostatic 
load, sleep and allostatic load, and individual differences related to these three main 
concepts are summarized here.   
Cancer 
Individual Differences in Cancer 
Cancer does not impact all populations equally; the risk of cancer increases with 
age and there are disparities in cancer for sex, race, and socioeconomic status.  A 
relationship between increasing age and the risk of cancer is well established.  The 
median age at cancer diagnosis is 66 (National Cancer Institute, 2015b).  Less than 10% 
of all new cancers occur in ages 44 and below, meaning 90% of new cancers occur in 
middle aged and older adults (National Cancer Institute, 2015b). In the US, men are more 
likely to be diagnosed with cancer and die from cancer than women.  The age-adjusted 
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incidence rate of cancer among men in U.S. was 480 per 100,000 in 2014 but only 426 
per 100,000 among women (National Cancer Institute, n.d.-c).  In 2014, the mortality rate 
for men was 194 per 100,000, but only 138 per 100,000 for women (National Cancer 
Institute, n.d.-c).  Similarly, there are racial disparities in cancer.  The incidence rate of 
cancer in white Americans was 460 per 100,000 in 2014 (National Cancer Institute, n.d.-
c).  For black Americans, the incidence rate of cancer was 453 per 100,000 in 2014 
(National Cancer Institute, n.d.-c).   Interestingly, the mortality rate for white Americans 
at 446 per 100,000 is slightly higher than the rate for black Americans at 434 per 
100,000. (National Cancer Institute, n.d.-c).  Breaking down racial disparities in cancer 
incidence by gender/sex,  white women have a higher cancer incidence (430 per 100,000) 
than black women (389 per 100,000) (National Cancer Institute, n.d.-c).  The opposite is 
true of men.  Black men have a higher incidence rate of cancer (503 per 100,000) than 
white men (474 per 100,000) (National Cancer Institute, n.d.-c).  Lastly, there is evidence 
that socioeconomic factors, such as education and income, are linked with cancer 
mortality outcomes, but less is known about these relationships.  One recent study of 
cancer outcomes and socioeconomic factors examined over 60 years of cancer data in 
relation to U.S. Census derived socioeconomic measures and found lower socioeconomic 
status (including variables for lower education and lower income) was associated with an 
increase in cancer incidence and cancer mortality (Singh & Jemal, 2017).   
Cognitive-Behavioral Responses to Stress and Cancer 
Alcohol, tobacco and physical activity have known links to cancer.  The U.S. 
Department of Health and Human Services and the International Agency for Research on 
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Cancer both label alcohol as a carcinogen (International Agency for Research on Cancer 
& Weltgesundheitsorganisation, 2012; National Cancer Institute, 2013).  It is estimated 
that 3.2-3.7% of cancer deaths annually are attributable to alcohol (Nelson et al., 2013).  
Smoking has long been known to be a carcinogen and is a risk factor for developing 
many types of cancer (National Cancer Institute, 2014).  Of the 480,000 annual deaths in 
the US attributable to tobacco, 36% are due to cancer (U.S. Department of Health and 
Human Services, 2014).   Lastly, increasing levels of physical activity have been shown 
to reduce the risk of cancer (National Cancer Institute, 2017a). 
There is a possible relationship between cancer and depression.  In the US, the 
prevalence of depression is 7.6%. (Pratt & Brody, 2014).  There is an increased risk of 
depression among some patients with cancer, such as those in pain or those experiencing 
physical weakness (National Cancer Institute, 2017b).  A systematic review of studies 
examining depression in adults with cancer found that the prevalence of depression 
among cancer patients to be up to 16% in outpatients, 14% in inpatients, and 49% in 
palliative care (J. Walker et al., 2013).  A study of the prevalence of depression by 
specific cancer types found the prevalence of depression to be lowest among those with a 
genitourinary cancer (5.6%) and highest among those with lung cancer (13.1%) (Jane 
Walker et al., 2014).  There is some limited evidence that depression may be linked to 
cancer incidence, but the evidence is not definitive.  It appears that chronic depression 
may be linked with cancer incidence (Currier & Nemeroff, 2014).  There is less study of 
a link between depressive symptoms and future cancer occurrence (Currier & Nemeroff, 
2014).     
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NCI identifies additional risk factors for cancer, including chronic inflammation, 
diet, hormones, immunosuppression, infectious agents, obesity, radiation, and sunlight 
(National Cancer Institute, 2015a).  Cancer-causing substances such as asbestos as well 
as other chemical exposures also are risk factors for cancer (National Cancer Institute, 
2015a).  Two areas that have received little attention in relation to cancer occurrence are 
responses to stress.  Sleep, a cognitive-behavioral response to stress, and allostatic load, a 
physiological response to stress, are two concepts that need further study.   Sleep 
problems are known to be an issue for cancer patients, but prevalence and causes are not 
firmly established (Otte et al., 2015).  Even less is known about sleep and future cancer 
occurrence.  Virtually no attention has been given to a potential relationship between 
allostatic load and future cancers.  
Sleep 
Sleep is a biological human requirement and essential for human functioning.   
During the sleep state, physiologic changes occur, such as reduced blood pressure and 
temperature, increased cellular repair, and changes in brain activity (Harvard Medical 
School, Division of Sleep Medicine, 2007).  Sleep is also a health behavior (Perry et al., 
2013).  Timing, duration, and quality of sleep can be consciously affected, and research 
shows variations in these aspect of sleep based on personal choices and environmental 
influences such as work schedules and use of social media (Perry et al., 2013).  There is 
no single definition of healthy sleep, and sleep is comprised of several distinct domains, 
including sleep quality, sleep latency (how long it takes to fall asleep), sleep duration, 
sleep efficiency (difference between time spent in bed trying to sleep and time spent 
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asleep), sleep disturbances, and daytime dysfunction (impairments in daily functioning 
due to sleep problems).  Sleep problems are common in the United States, and sleep 
duration is the most commonly studied domain.  The prevalence of short sleep duration 
(<7 hours per day) among adults ranged 26.3-39.0% depending on age group in 2014 
(Centers for Disease Control and Prevention, 2017b).  The prevalence of long sleep 
duration (>9 hours per day) was 37.2% among all adults in 2007 (Bin et al., 2013).   
Sleep and Individual Differences 
Sleep duration requirements are dependent on age.  The National Sleep 
Foundation updated their recommended sleep time durations by age in 2015 (Hirshkowitz 
et al., 2015a).  For young adults and adults up to age 64, 7 to 9 hours per night is 
considered healthy (Hirshkowitz et al., 2015a).  For older adults 65 and older, 7 to 8 
hours of sleep per night is needed (Hirshkowitz et al., 2015a).  The prevalence of sleep 
disturbances also varies by age, with the highest prevalence being among those 18-24 
(18.1% for men and 25.1% for women) and the lowest among older adults (M.A. 
Grandner, 2017).  Lastly, risk for sleep disorders, such as insomnia and sleep apnea, 
increases with age (M.A. Grandner, 2017).   
The relationship between sleep and gender is less well established.  A study of a 
nationally representative sample found that men have a shorter sleep duration than 
women, but that this relationship became non-significant after controlling for other 
factors such as family structure and socioeconomic status variables (Krueger & 
Friedman, 2009).  In contrast, another study of a nationally representative sample found a 
statistically significant difference in sleep duration between men and women  (Burgard & 
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Ailshire, 2013).  Women in the study were found to sleep 11 minutes more per night than 
men (Burgard & Ailshire, 2013).  Women also were more likely to have interrupted sleep 
and were more likely to nap compared to men (Burgard & Ailshire, 2013).  Women 
report more sleep disturbances compared with men and are more likely to report 
insomnia, while men are at higher risk for sleep apnea (M.A. Grandner, 2017).   
There is evidence of racial and socioeconomic differences in sleep.  Black 
Americans have an increased likelihood of short sleep duration and poor sleep quality 
compared to white Americans (X. Chen et al., 2015; Krueger & Friedman, 2009).  Black 
Americans are also more likely to have a long sleep duration than white Americans 
(Krueger & Friedman, 2009).  Studies of sleep and socioeconomic factors have shown 
that low education level was associated with poor sleep (Michael A. Grandner et al., 
2013, 2015). Low income also has been found to be associated with poor sleep (Michael 
A. Grandner et al., 2015).  Low income and low education are linked to both short and 
long sleep duration (Krueger & Friedman, 2009).  Race and socioeconomic factors 
frequently confound each other in research on disparities in sleep (M.A. Grandner, 2017).   
Sleep and Cognitive-Behavioral Responses to Stress 
Cognitive-behavioral factors are also related to sleep.  Researchers have found 
links between sleep problems and alcohol, tobacco, physical activity and depression.  
Alcohol dependence is associated with insomnia, short sleep duration, sleep apnea, and 
circadian disruptions (Chakravorty, Chaudhary, & Brower, 2016).  Even a single night 
where 1-2 drinks are consumed in the evening before sleep has been shown to disrupt 
sleep (Ebrahim, Shapiro, Williams, & Fenwick, 2013).  Similarly, smoking is associated 
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with poor sleep quality and shorter sleep duration (Cohrs et al., 2014; Michael A. 
Grandner et al., 2015; Zhang, Samet, Caffo, & Punjabi, 2006).  Researchers report a link 
between sleep and physical activity level.  In one study using a nationally representative 
sample, subjects with at least 150 minutes of moderate physical activity per week or 75 
minutes of vigorous activity per week reported less daytime sleepiness than subjects who 
were more physically inactive (Loprinzi & Cardinal, 2011).  In an experiment examining 
the impact of physical activity on sleep, young adults in the control group were sedentary 
for one week while the control group maintained their usual physical activity levels 
(Edwards & Loprinzi, 2017).  The sedentary group experienced decreases in subjective 
sleep quality post-intervention (Edwards & Loprinzi, 2017).  Lastly, sleep problems and 
depression are frequently co-morbid and share correlates (Herrick & Sateia, 2016; Poole 
& Jackowska, 2017).  In fact, having insomnia or hypersomnia is one the diagnostic 
criteria for major depression (American Psychiatric Association, 2013).  Specific sleep 
problems such as increased insomnia symptoms and increasing number of nighttime 
awakenings are associated with depression (Taylor, Lichstein, Durrence, Reidel, & Bush, 
2005).  Also, depression is associated with self-report of poor sleep satisfaction (Mayers, 
Grabau, Campbell, & Baldwin, 2009).   
Sleep and Health Outcomes  
Compromised sleep can have significant consequences, including cognitive 
impairment, morbidity and mortality.  There is a substantial body of work on how sleep 
impacts cognition.  Killgore (2010) provides a thorough summary of known sleep-
cognition relationships.  In sum, alertness, vigilance, attention, motor-tracking, 
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visuospatial perception, auditory perception, olfactory perception, memory formation, 
learning, and creativity are all impacted negatively by sleep deprivation (Killgore, 2010).  
Additionally, sleep deprivation is associated with increased negative mood, depression, 
anxiety, paranoia, decreased emotional intelligence, increased risk-taking, poorer 
judgement, reduced empathy, feelings of persecution and slower decision-making 
(Killgore, 2010).  Lastly, sleep deprivation is associated with increased somatic 
complaints and hyperalgesia (Killgore, 2010).   
Sleep and Morbidity 
Sleep problems have been studied for their impact on physical health.  For 
example, sleep has been studied in relation to diseases such as hypertension and diabetes 
as well as in relation to other health problems such as obesity.  Shorter sleep duration has 
been found to have health consequences.  Meta-analyses with large pooled sample sizes 
have concluded that shorter sleep is associated with an increased odds of obesity and an 
increased odds of metabolic syndrome (Cappuccio et al., 2008; Ju & Choi, 2013).  Cross 
sectional and longitudinal data have demonstrated higher systolic and diastolic blood 
pressure and hypertension with short sleep duration (Knutson et al., 2009).  A population-
based, prospective study of Taiwanese adults reported an increased risk of coronary heart 
disease with short sleep duration (Lao et al., 2018).  In contrast, a prospective study of 
adult women in the US found no significant relationship between short or long sleep 
duration and risk of cardiovascular disease, but did find an increase disease risk in 
women with long sleep duration and women with insomnia (Sands-Lincoln et al., 2013).  
A meta-analysis with a large pooled sample size found short sleep duration to be 
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associated with an increased relative risk of diabetes (Cappuccio et al., 2010).  Less study 
has been devoted to long sleep duration and health outcomes, but meta-analyses have 
shown long sleep duration to be associated with an increased odds of metabolic syndrome 
and an increased relative risk of diabetes (Cappuccio et al., 2010; Ju & Choi, 2013).   
Other sleep parameters beyond sleep duration have been examined in relation to 
health problems.  Difficulty initiating sleep and difficulty maintaining sleep are 
associated with an increased relative risk of diabetes, and (Cappuccio et al., 2010).  
Difficulty falling asleep and use of sleep medications are associated with an increased 
risk of coronary heart disease (Lao et al., 2018).  A large longitudinal study found that 
difficulty initiating sleep every night,  difficulty maintaining sleep every night and 
feelings of nonrestorative sleep more than once a week were all associated with a 
moderate increase in risk of acute myocardial infarction (Laugsand et al., 2011).  Chronic 
insomnia (defined as insomnia for more than one year) is associated with a higher odds of 
diabetes and with a higher odds of hypertension (Alexandros N. Vgontzas, Liao, Pejovic, 
et al., 2009; Alexandros N. Vgontzas, Liao, Bixler, Chrousos, & Vela-Bueno, 2009).  In 
the studies of chronic insomnia, those at greatest risk for diabetes and hypertension were 
those that experienced both chronic insomnia and short sleep duration (Alexandros N. 
Vgontzas, Liao, Pejovic, et al., 2009; Alexandros N. Vgontzas, Liao, Bixler, et al., 2009).   
Sleep and Mortality 
Problems with sleep are associated with an increased all-cause mortality risk, 
although the evidence is not yet conclusive.  A meta-analysis of almost 1.4 million adults 
found that both short and long sleep duration is associated with an increase in all-cause 
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mortality (Cappucio et al., 2010).  A separate meta-analysis of just over 2.2 million adults 
showed similar results, however, analyses of men and women separately found that short 
sleep duration in females was associated with increased all-cause mortality risk but short 
sleep duration in males was not (T.-Z. Liu et al., 2017).  A separate study of insomnia 
found the opposite effect; all-cause mortality risk was increased in men with insomnia 
with short sleep duration, but not for women with insomnia with short sleep duration 
(Alexandros N. Vgontzas et al., 2010).   
  There is limited evidence that sleep problems impact cause-specific mortality.  
One longitudinal study of men and women in the United Kingdom assessed sleep at 
baseline and then followed participants for 22 years (Rod et al., 2014).  In men, neither 
short sleep duration nor self-reported disturbed sleep were associated with mortality from 
cardiovascular (CV) disease, however, men who experienced both short sleep duration 
and disturbed sleep at baseline had a higher risk of future CV mortality (Rod et al., 2014).  
In women, both short sleep duration and self-reported disturbed sleep at baseline were 
both independently associated with increased risk of CV mortality (Rod et al., 2014).  
Women with both short sleep duration and disturbed sleep had the highest risk of CV 
mortality (Rod et al., 2014).  Researchers also examined the relationships between other 
causes of death (including cancer), and found no relationship (Rod et al., 2014).  A meta-
analysis synthesizing the results of 19 studies concluded both short and long sleep 
duration are associated with an increased risk for cardiovascular mortality (Krittanawong 
et al., 2017).  
   
 
 
 
31 
Sleep and Cancer 
Sleep has long been established as a problem for people with cancer.  There are 
studies examining sleep in cancer patients at various stages of the cancer experience, 
including before, during and after treatment, and during survivorship.  The sleep issues 
studied include subjective sleep quality, disturbed sleep, and insomnia. The majority of 
the research on cancer and sleep has been done in patients with breast cancer.   
Cancer and sleep prior to treatment.  A number of studies were identified that 
investigated sleep in cancer patients prior to the initiation of a particular cancer treatment.  
In general, a substantial number of patients with cancer begin cancer treatment with sleep 
problems.  Longitudinal and cross-sectional studies have documented that subjective 
sleep quality is poor in women with breast cancer after surgical intervention but prior to 
the initiation of chemotherapy (Ancoli-Israel et al., 2006; L. Liu et al., 2012).  The 
longitudinal results show that not only is sleep quality poor prior to the start of 
chemotherapy, but poor sleep quality persists throughout treatment (L. Liu et al., 2012).  
A small number of studies examined the prevalence of sleep problems prior to 
undergoing a specific treatment (surgery, radiation therapy, chemotherapy, or hormone 
therapy). Poor self-reported sleep quality has been found in ovarian cancer patients 
undergoing surgical intervention and in cervical cancer patients prior to initiating 
chemotherapy or radiation therapy, (Lauren Clevenger et al., 2012; Tian et al., 2015).  
Similarly, a study of patients with a variety of types of cancers have found patients had 
disturbed sleep prior to undergoing radiation therapy (Hickok, Morrow, Roscoe, Mustian, 
& Okunieff, 2005).  Lastly, a study of patients with a variety of cancers prior to the 
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initiation of any non-surgical therapy found that the majority met criteria for insomnia 
syndrome or reported insomnia symptoms (Savard, Villa, Ivers, Simard, & Morin, 2009).  
A significant problem with the studies reporting on sleep problems prior to cancer 
treatment initiation is that the majority of them do not specify if patients had already 
undergone other treatment modalities prior to the start of the study.  Only two studies 
(Ancoli-Israel et al., 2006; Tian et al., 2015) document if patients had already undergone 
a treatment prior to initiation of the one under study; the remainder of the studies 
reviewed do not document whether or not patients had experienced prior therapies which 
limits the conclusions that can be drawn.   
Cancer and sleep during and after treatment.  Few studies of sleep problems in 
cancer patients during and after treatment were identified.  In a very small study of lung 
cancer patients, most were found to be self-reported poor sleepers and poor sleepers had a 
short sleep duration while undergoing treatment with chemotherapy (Dean et al., 2013).  
A study of patients with a variety of cancers found 43% had insomnia syndrome after 
initiating chemotherapy (Palesh et al., 2010).  One study examined sleep problems before 
and after initiating treatment and found an increased prevalence of sleep problems during 
treatment (Tian et al., 2015).  One study was identified that examined sleep in breast 
cancer patients immediately post-treatment; researchers found 65% of them reported poor 
subjective sleep quality (Bower et al., 2011).   
Cancer survivors and sleep.  A few studies have examined sleep problems in 
cancer survivors at time points beyond diagnosis and treatment.  Longitudinal studies, 
one of ovarian cancer survivors and one of survivors of a variety of cancers, have 
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demonstrated that some cancer patients report poor subjective sleep quality and insomnia 
up to 12 to 18 months after diagnosis (L. Clevenger et al., 2013; Savard, Ivers, Villa, 
Caplette-Gingras, & Morin, 2011).  Sleep problems in long-term cancer survivors have 
also been studied.  Two studies of breast cancer survivors with non-metastatic disease 
have shown over one-third of survivors had insomnia symptoms or short sleep duration 
four or more years after diagnosis (Bardwell et al., 2008; Klyushnenkova et al., 2015).  
Only one study was identified of cancer patients at the end of life.  In 219 patients 
admitted to a palliative care unit with a variety cancers in advanced stages, 100% of them 
were found to have sleep disturbances (Mercadante et al., 2017).   
Factors associated with sleep problems in cancer.  Few studies have examined 
factors associated with sleep problems in cancer patients beyond tumor and treatment-
related factors.  Some of the other factors that have been studied include coping 
strategies, depression, anxiety, fatigue, gender, and cancer symptoms. Unfortunately, 
rarely was more than one study identified for each factor studied, limiting the conclusions 
that can be drawn.  Avoidance coping has been shown to be associated with worse sleep 
in breast cancer and prostate cancer patients during treatment with radiation therapy 
(Thomas, Bower, Hoyt, & Sepah, 2010).  Insomnia is associated with depression and 
anxiety; insomnia was significantly worse for those with increased levels of anxiety and 
depression among cancer patients in a palliative care unit (Bardwell et al., 2008; 
Mercadante et al., 2017; Palesh et al., 2010; Savard et al., 2011).  Fatigue is worse in 
cancer patients receiving chemotherapy who have insomnia (Palesh et al., 2010).  
Dysfunctional beliefs about sleep and poor sleep behaviors are associated with an 
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increased risk of insomnia in cancer patients undergoing treatment (Savard et al., 2009). 
Women with cancer have an increased risk of insomnia compared with men (Savard et 
al., 2009).   
Cancer outcomes and sleep.  Only two studies were identified that investigated 
sleep in relation to cancer outcomes.  In a small study of lung cancer patients undergoing 
treatment, those with insomnia had more reported symptoms related to cancer (Dean et 
al., 2013).  In a much larger sample (>3000) of survivors of early-stage breast cancer, 
women who consistently had a short or long sleep duration over time did not have 
increased risks of disease recurrence or cause-specific or all-cause mortality (Marinac et 
al., 2017).   
Future cancer occurrence and sleep.  As sleep has been increasingly studied as 
a potential risk factor for disease, interest in sleep problems as risk factors for cancer has 
grown.  However, there have been few studies examining this.  Sleep duration is the most 
studied sleep parameter.  Studies of sleep duration and risk of breast cancer have not 
found a link between sleep duration and incidence of breast cancer (Qin et al., 2014; 
White et al., 2017).  However, there is evidence demonstrating that shorter sleep duration 
may be associated with more aggressive breast cancer type (Soucise et al., 2017; 
Thompson & Li, 2012).  Two studies found short sleep duration has been shown to be 
associated with colon cancer (Jiao et al., 2013; Thompson et al., 2011).  One study found 
long sleep duration was associated with an increased risk of colon cancer (Jiao et al., 
2013).  Other researchers found no link between colon cancer and sleep duration (Devore 
et al., 2017).  Longitudinal studies from Finnish men and male and female rural residents 
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of China found an increased incidence of lung cancer with short sleep duration and long 
sleep duration among Finnish and Chinese men and among Chinese women (Luojus et 
al., 2014; Wong et al., 2017).  A prospective cohort study of adult women reported an 
increased risk of liver cancer among women with long sleep duration, with the highest 
risk being among obese women (Royse et al., 2017).   
One challenge in interpreting the findings from studies of sleep duration and 
cancer risk is the wide variation in operationalization of short sleep duration and long 
sleep duration.  Studies of short sleep duration defined it as four, five, six, six and a half, 
or seven hours of sleep per night (Devore et al., 2017; Jiao et al., 2013; Luojus et al., 
2014, 2014; Qin et al., 2014; Royse et al., 2017; Soucise et al., 2017; Thompson et al., 
2011; Thompson & Li, 2012; Wong et al., 2017).  Studies of long sleep duration defined 
it as greater than 8 hours, 9 hours or 10 hours of sleep per night (Devore et al., 2017; Jiao 
et al., 2013; Luojus et al., 2014; Qin et al., 2014; Royse et al., 2017; Soucise et al., 2017; 
Wong et al., 2017).  All the studies reviewed used a priori definitions of short and long 
sleep duration, none explored the data for possible sleep duration cut points.   
Other sleep parameters, such as sleep quality, have been studied less in relation to 
risk of future cancer.  Difficulty sleeping has been shown to be associated with an 
increased risk of breast cancer and self-reported average or poor sleep quality was 
associated with more aggressive breast cancer among African-American women (Soucise 
et al., 2017; White et al., 2017).  A study from Norway demonstrated an increased risk of 
breast cancer in women who reported having nonrestorative sleep, difficulty initiating 
sleep, and difficulty maintaining sleep; women with only one or two insomnia symptoms 
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did not show an increased risk of breast cancer (Sen et al., 2017).  Self-reported difficulty 
falling asleep and difficulty staying asleep were associated with an increased risk of 
prostate cancer among Icelandic men (Sigurdardottir et al., 2013). A retrospective study 
using Taiwan’s National Health Insurance Research Database (which covers 98% of 
Taiwan’s population), found an increased risk of breast cancer, nasal cancer, liver cancer, 
cervical cancer, oral cancer colon cancer lymphatic cancer, thyroid cancer, myeloma, 
prostate cancer, bladder cancer, kidney cancer and other cancers among those with a 
diagnosis of insomnia at least 2 years prior to cancer diagnosis (Fang et al., 2015).   
Allostatic Load 
 Allostatic load is a physiologic response to stress.  Research has demonstrated 
allostatic load is impacted by a spectrum of life factors, including childhood experiences, 
social relationships, discrimination, caregiving, workplace issues, personal psychological 
characteristics, and neighborhood factors (Bird et al., 2010; Brooks et al., 2014; Judith E. 
Carroll et al., 2013; E. Chen, Miller, Lachman, Gruenewald, & Seeman, 2012; de Castro, 
Voss, Ruppin, Dominguez, & Seixas, 2010; Friedman, Karlamangla, Gruenewald, 
Koretz, & Seeman, 2015; Gallo, Jiménez, Shivpuri, Monteros, & Mills, 2011; Hasson, 
Von Thiele Schwarz, & Lindfors, 2009; Hawkley, Lavelle, Berntson, & Cacioppo, 2011; 
Mair, Cutchin, & Kristen Peek, 2011; Merkin et al., 2009; Ong, Williams, Nwizu, & 
Gruenewald, 2017; Robinette, Charles, Almeida, & Gruenewald, 2016; Roepke et al., 
2011; Slopen, Chen, Priest, Albert, & Williams, 2016; Song et al., 2014; Sun, Wang, 
Zhang, & Li, 2007; Upchurch et al., 2015; Utumatwishima et al., 2017; Vadiveloo & 
Mattei, 2017; van Deurzen et al., 2016; Zilioli, Slatcher, Ong, & Gruenewald, 2015).  
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Allostatic load has been shown to vary by individual differences and cognitive-behavioral 
factors and it has been linked with health outcomes, including morbidity and mortality.   
Allostatic Load and Individual Differences 
Studies have shown age to have a significant relationship with AL (Crimmins, 
Kim, & Seeman, 2009; Hasson et al., 2009; Robinette et al., 2016; Schnorpfeil et al., 
2003; T. Seeman et al., 2004; T. E. Seeman, Singer, Ryff, Love, & Levy-Storms, 2002; 
Sun et al., 2007).  One study was identified that did not find a relationship between 
increasing age and increased allostatic load among Japanese elders (Kusano et al., 2016).  
While age is universally included as a covariate in studies of AL, only one study 
investigated the age-allostatic load relationship directly.  Crimmins et al (2003) used 
nationally representative US data to demonstrate that allostatic load gradually increases 
over the early/mid decades of adulthood to essentially plateau after age 65 in the US.  
Allostatic load increases by 0.4-0.5 units every 5 years in the 20’s and 30’s, then 
allostatic load increases by 0.2-0.3 units every 5 years in the 40’s and 50’s before 
leveling off at around age 65 (Crimmins et al., 2003).   
Similar to studies of age and allostatic load, gender is typically included in studies 
investigating allostatic load as a covariate, but few studies have studied the gender-AL 
relationship directly.  A nationally representative sample of adults in the US 
demonstrated that women had higher AL scores compared with men (Geronimus, 
Hicken, Keene, & Bound, 2006).  Conversely,  a study of black, white, and Hispanic 
older adults in Chicago and a study of elderly Japanese both found men to have higher 
AL scores compared with women (Hawkley et al., 2011; Kusano et al., 2016).   
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Numerous studies have investigated the relationship between race and/or ethnicity 
and allostatic load.  The majority of those reviewed focused on black/white differences.  
Most studies including black participants found that black race is associated with higher 
AL (Chyu & Upchurch, 2011; Geronimus et al., 2006; Kaestner, Pearson, Keene, & 
Geronimus, 2009; Mair et al., 2011; Merkin et al., 2009; Parente et al., 2013; Tomfohr, 
Pung, & Dimsdale, 2016; Wallace et al., 2013).  The percent of the sample that was black 
in the studies finding black race associated with higher allostatic load ranged from 12-
43% (Chyu & Upchurch, 2011; Geronimus et al., 2006; Kaestner et al., 2009; Merkin et 
al., 2009; Parente et al., 2013; Peek et al., 2010; Tomfohr et al., 2016; Wallace et al., 
2013).  Some studies adjusted for various covariates and some studies did not account for 
covariates.  Two studies reviewed found no racial differences in AL (Hawkley et al., 
2011; T. Seeman et al., 2010).  Of these two studies, one was a study that used SEM 
methods to study allostatic load with 55% black participants (in contrast to the regression 
analyses using composite allostatic load typically used), and one was a study of older 
adults with equal percentages of black, white and Hispanic participants (Hawkley et al., 
2011; T. Seeman et al., 2010).  Using typical regression analyses with composite 
allostatic load, the evidence supports the idea that black race is associated with higher 
allostatic load.  It is less obvious what to conclude if the two contrasting results studies 
are included given that their samples and/or methods are different from the majority of 
the studies reviewed.   
A number of studies have investigated the possibility of a relationship between 
allostatic load and socioeconomic status (SES).  SES has been operationalized in a 
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variety of ways, including poverty status, education, occupation, income, self-reported 
financial status as compared to others, self-assessed current financial status, difficulty 
paying bills, and/or a composite index of some of these variables (Crimmins et al., 2009; 
Geronimus et al., 2006; Glei, Goldman, Chuang, & Weinstein, 2007; Gruenewald et al., 
2012; Hawkley et al., 2011; Kubzansky, Kawachi, & Sparrow, 1999; T. Seeman et al., 
2008; T. E. Seeman et al., 2004; Upchurch et al., 2015; Weinstein, Goldman, Hedley, 
Yu-Hsuan, & Seeman, 2003).  One study from Taiwan added sex to their composite SES 
measure (Weinstein et al., 2003).  Regardless of how SES was measured, each study 
reviewed found that lower SES was associated with higher allostatic load (Crimmins et 
al., 2009; Geronimus et al., 2006; Glei et al., 2007; Gruenewald et al., 2012; Hawkley et 
al., 2011; Kubzansky et al., 1999; T. Seeman et al., 2008; T. E. Seeman et al., 2004; 
Upchurch et al., 2015; Weinstein et al., 2003). Two studies examined potential mediators 
for the SES-AL relationship (Hawkley et al., 2011; Upchurch et al., 2015). In a study of 
middle aged US women ages 42-52, perceived stress, discrimination and hostility 
mediated relationship between income and allostatic load while perceived stress and 
hostility mediated relationship between education and allostatic load (Upchurch et al., 
2015).  A separate study of older US adults ages 51-69 examined stress, personality, 
psychosocial factors, coping, social networks and health behaviors as potential mediators 
of the SES-allostatic load association; of the variables examined, only poor sleep quality 
and hostility mediated the SES-allostatic load relationship (Hawkley et al., 2011).  
In addition to being used as a proxy for SES or as part of a composite of SES, 
education level and income have been treated as an independent item in studies of 
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allostatic load.  Frequently studies will control for education level or income but do not 
examine them or report on their impact on allostatic load directly.  As with the studies 
using education as a factor in composite SES, lower education levels alone have been 
found to be associated with increased levels of allostatic load after controlling for 
sociodemographic and lifestyle factors (Chyu & Upchurch, 2011; Hux, Roberts, & Okun, 
2017; T. Seeman et al., 2008; T. E. Seeman et al., 2004; Sun et al., 2007; Upchurch et al., 
2015; Weinstein et al., 2003).  Fewer studies have looked at income alone, but the 
available evidence indicates higher income is associated with lower allostatic load (Chyu 
& Upchurch, 2011).  One study directly examined the relationship between poverty status 
and allostatic load (Crimmins et al., 2009).  People who were poor had higher allostatic 
load than those who are not poor in their 20’s, 30’s, 40’s, 50’s, 60’s and 70’s (Crimmins 
et al., 2009).  The effect disappeared in later ages (Crimmins et al., 2009).   
Allostatic Load and Cognitive-Behavioral Responses to Stress  
There is significantly less evidence about the relationship between allostatic load 
and the cognitive-behavioral factors of alcohol, tobacco, physical activity and depression.  
Only two studies were identified that examined lifestyle factors, including alcohol, 
tobacco, and physical activity, and allostatic load.  One study reported that alcohol use 
predicted higher allostatic load in men but not in women (Hampson, Goldberg, Vogt, 
Hillier, & Dubanoski, 2009), while the other found no relationship between alcohol and 
allostatic load after controlling for covariates (Gustafsson, Janlert, Theorell, Westerlund, 
& Hammarström, 2011).  Both studies found that smoking predicted higher allostatic load 
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in men but not in women, and reported that low physical activity predicted higher 
allostatic load in men but not in women (Gustafsson et al., 2011; Hampson et al., 2009).     
The relationship between depression and allostatic load is not well established, 
but there is some limited evidence linking depression and allostatic load.  In a study using 
a nationally representative sample, higher allostatic load was associated with increased 
depressive symptoms (Kobrosly, Seplaki, Cory-Slechta, Moynihan, & van Wijngaarden, 
2013).  Similar results were found in a study of community-based older adults (average 
age 76) (Kobrosly, van Wijngaarden, Seplaki, Cory-Slechta, & Moynihan, 2014).  In a 
longitudinal study of older adults followed for six years, increased AL was associated 
with increased depressive symptoms in the same year of measurement, but there was no 
relationship between baseline allostatic load and future depressive symptoms (Juster, 
Marin, et al., 2011).  A cross-sectional study of healthy workers from various professions 
found no association between allostatic load and depression (Juster, Sindi, et al., 2011).  
Allostatic Load and Sleep 
Studies of sleep duration and allostatic load have shown mixed results.  Some 
studies have found short sleep duration to be associated with increased allostatic load, 
others have shown conflicting results; the same is true for studies of long sleep duration 
and allostatic load (J.E. Carroll et al., 2015; X. Chen et al., 2014; Clark et al., 2014).  As 
with studies of sleep and future cancer, operationalization of short and long sleep 
duration was variable.  Allostatic load has also been examined in relation to sleep 
disorders.  The prevalence of increased mean allostatic load was high among adults with 
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sleep apnea, snoring, snorting/stop breathing, insomnia and diagnosed sleep disorders 
compared with persons without any sleep disturbances (X. Chen et al., 2014).  
 Only one study was identified that examined subjective sleep quality and 
allostatic load.  In this study, black race was associated with allostatic load and this 
relationship was mediated in part by subjective sleep quality (Tomfohr et al., 2016).  In 
serial mediation analyses, Tomfohr et al (2016) showed that there was a relationship 
between black race and discrimination, which was then related to the experience of anger, 
which then impacted subjective sleep quality, which then resulted in an increased 
allostatic load.  This validates the conceptual framework for stress response depicted in 
Figure 1.  
Although few studies of sleep and overall allostatic load were identified for 
review, some studies of sleep and individual biomarkers thought to be associated with 
allostatic load were found.  Experimental sleep deprivation has been shown to reduce 
insulin sensitivity, impair glucose tolerance, and reduce insulin secretion (Broussard, 
Ehrmann, Van Cauter, Tasali, & Brady, 2012; Gonnissen, Hursel, Rutters, Martens, & 
Westerterp-Plantenga, 2013; Nedeltcheva, Kessler, Imperial, & Penev, 2009; Spiegel, 
Leproult, & Van Cauter, 1999; Van & Spiegel, 1999). Experimental sleep fragmentation 
and sleep deprivation have been shown to be associated with an increase in blood 
pressure readings and an increased risk for hypertension (Carrington & Trinder, 2008; 
Mullington, Haack, Toth, Serrador, & Meier-Ewert, 2009; Palagini et al., 2013).  
Similarly, self-reported short sleep duration and long sleep duration were associated with 
increased odds of having hypertension compared with normal (Gottlieb et al., 2006).  
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Sleep restriction has also been shown to impact heart rate variability in the direction of 
sympathetic activation (Spiegel et al., 1999; Van & Spiegel, 1999).   
Half of the identified studies of experimental sleep deprivation and cortisol show 
altered cortisol levels by reducing levels and flattening diurnal rhythms, and the other 
half found cortisol levels increased or unchanged with sleep deprivation (Nedeltcheva et 
al., 2009; Omisade, Buxton, & Rusak, 2010; Pejovic et al., 2013; Redwine, Hauger, 
Gillin, & Irwin, 2000; Spiegel et al., 1999; Van & Spiegel, 1999; A. N. Vgontzas et al., 
2004; von Treuer, Norman, & Armstrong, 1996; Wright et al., 2015). A handful of 
experimental studies have shown sleep deprivation increases IL-6 production (Irwin, 
Wang, Campomayor, Collado-Hidalgo, & Cole, 2006; Irwin et al., 2015; Pejovic et al., 
2013; Redwine et al., 2000; A. N. Vgontzas et al., 2004).  A systematic review of 72 
studies of inflammation and sleep found that short sleep duration was associated with 
higher CRP and that long sleep duration was associated with higher CRP and IL-6 (Irwin, 
Olmstead, & Carroll, 2016).  A longitudinal study found that insomnia and short sleep 
duration at baseline was associated with higher CRP and IL-6 five years later (Cho, 
Seeman, Kiefe, Lauderdale, & Irwin, 2015).  Experimental sleep deprivation has been 
shown to be associated with increased epinephrine and norepinephrine (Nedeltcheva et 
al., 2009).   
There are two studies that have examined the effects of sleep problems in natural 
settings.  Among undergraduate men, shorter cumulative sleep time was associated with 
decreased heart rate variability during stress tests and prolonged increases in heart rate 
and diastolic blood pressure after stress tests (Mezick, Matthews, Hall, Richard Jennings, 
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& Kamarck, 2014).  Among middle-aged women, higher sleep latency (or the time it 
takes to go from a fully awakened state to sleep) was associated with increased CRP, IL-6 
and insulin resistance (Kim et al., 2016).     
Allostatic Load and Health Outcomes 
Physical and cognitive functioning.  A few studies have examined allostatic load 
in relation to physical functioning and cognitive functioning.  In terms of physical 
functioning, high allostatic load at baseline has been shown to be associated with worse 
physical functioning over time among the elderly (Karlamangla, Singer, McEwen, Rowe, 
& Seeman, 2002; T. E. Seeman, McEwen, Rowe, & Singer, 2001; T. E. Seeman et al., 
1997).  Similarly, allostatic load has been shown to be associated with frailty among the 
elderly (Gruenewald, Seeman, Karlamangla, & Sarkisian, 2009; Szanton, Allen, Seplaki, 
Bandeen-Roche, & Fried, 2008).  A few longitudinal and cross-sectional studies have 
found that higher allostatic load is associated with worse cognitive functioning among the 
elderly (Karlamangla et al., 2014, 2002, T. E. Seeman et al., 2001, 1997).  One 
longitudinal study of cognitive functioning and allostatic load did not find a relationship 
between overall composite allostatic load and cognitive functioning, but instead 
identified an association between the higher secondary outcomes allostatic load subscore 
and worse cognitive functioning in an elderly sample (Goldman et al., 2006).  In the lone 
study of non-elderly subjects, patients with chronic fatigue syndrome with higher 
allostatic load had worse physical functioning; this relationship was not found among 
healthy controls (Goertzel et al., 2006).   
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Allostatic load and morbidity and mortality.  A few studies have examined 
relationships between allostatic load and various health outcomes.  Bone strength, 
chronic fatigue, delirium in hospitalized patients, and depression have been studied in 
relation to allostatic load.  Higher allostatic load was found to be associated with lower 
bone density among men and women (Mori et al., 2014).  Higher allostatic load was 
associated with worse bodily pain symptoms and more frequent, more intense fatigue 
symptoms among patients with chronic fatigue syndrome; this relationship was not found 
among healthy, non-fatigued controls (Goertzel et al., 2006).  Overall composite 
allostatic load was not associated with delirium in elderly hospitalized patients, however 
an increase in a subscore of allostatic load (that included cortisol, norepinephrine, 
epinephrine and DHEA-S) did predict the incidence of delirium (Rigney, 2010).   A 
longitudinal study of older adults found increased allostatic load was associated with 
increased depressive symptoms in the same year of measurement, but there was no 
relationship between baseline allostatic load and future depressive symptoms (Juster, 
Marin, et al., 2011).  A cross-sectional study of healthy workers from various professions 
reported no association between allostatic load and depression (Juster, Sindi, et al., 2011).  
Both studies had small sample sizes (58 and 30 participants respectively) (Juster, Marin, 
et al., 2011; Juster, Sindi, et al., 2011).  Lastly, studies of allostatic load and prevalent 
disease have indicated that higher AL was associated with abdominal obesity, 
hypertension, diabetes, cardiovascular disease and arthritis (Mattei, Demissie, Falcon, 
Ordovas, & Tucker, 2010; T. E. Seeman et al., 1997). Authors in a longitudinal study of 
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elder adults reported that baseline allostatic load was associated with the incidence of 
future cardiovascular events (T. E. Seeman et al., 2001).   
A few studies examined allostatic load and mortality, and despite differences in 
methods, all of them found that higher allostatic load was associated with an increased 
all-cause mortality risk (Borrell, Dallow, & Nguyen, 2010; Goldman et al., 2006; 
Karlamangla, Singer, & Seeman, 2006; Robertson, Beveridge, & Bromley, 2017; T. E. 
Seeman et al., 2004, 2001).  One study treated allostatic load as a mediator of the SES-
mortality relationship and found that allostatic load explained 35.4% of the difference in 
mortality risk between people who had high SES and people who had low SES (T. E. 
Seeman et al., 2004).  Similar to the studies of mortality, one study examined 
relationships between life expectancy, poverty and allostatic load (Crimmins et al., 2009).  
Those persons with the highest allostatic load levels had a life expectancy six years 
shorter than those persons with low allostatic load levels with similar poverty status and 
sex (Crimmins et al., 2009).  
Allostatic Load and Cancer 
Minimal investigation has been devoted to examining a potential relationship 
between allostatic load and cancer.  In a cross-sectional study of breast cancer disparities 
between black and white women, black women with breast cancer were found elevated 
allostatic load, but this was not found in white women (Parente et al., 2013).  This study 
used nine biomarkers of allostatic load from the cardiovascular, glucose, lipids, and 
inflammation domains of allostatic load (Parente et al., 2013).  In a study of Puerto 
Ricans living in Boston, prevalent cancer was not associated with AL in Puerto Ricans 
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living in Boston (Mattei et al., 2010).  This study used 10 biomarkers to comprise 
allostatic load from the HPA, sympathetic, cardiovascular, glucose and lipids domains of 
allostatic load (Mattei et al., 2010). 
The remaining studies reviewed below evaluated the relationship between cancer 
and individual biomarkers instead of overall AL.  Cortisol was the most commonly 
studied; flat cortisol patterns were found in subjects with cancer and were associated with 
decreased survival (Abercrombie et al., 2004; Bower et al., 2005; Cohen et al., 2012; 
Schrepf et al., 2015; S. E. Sephton et al., 2013; S. Sephton et al., 2000).      
 Preliminary research has demonstrated thyrotropin releasing hormone and growth 
hormone were higher in cancer patients prior to treatment while melatonin, thyroid 
stimulating hormone and IGF-I levels were higher in healthy controls (Mazzoccoli et al., 
2003). In cancer patients undergoing treatment vascular endothelial growth factor, 
soluble intercellular adhesion molecule-1 (sICAM-1), soluble P-selectin and von 
Willebrand factor were all found to be higher post-chemotherapy as compared to pre-
treatment levels (Mills et al., 2008).  Interleukin-6, interleukin-10, and sTNF-R1 all 
increased over the course of chemotherapy and radiation treatment (Wang et al., 2010).  
Additionally, IL-6 and sTNF-R1 were associated with increased severity of cancer-
related symptoms of fatigue and disturbed sleep (Wang et al., 2010).   
Only one study was identified that investigated biomarkers as predictors of future 
cancer occurrence.  A large case-cohort study from Italy (n=22,494) found that high 
blood glucose was associated with an increased risk in breast cancer up to 15 years later; 
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other biomarkers (cholesterol, blood pressure, obesity) were not associated with breast 
cancer risk (Agnoli et al., 2015).   
Summary 
The conceptual framework guiding this inquiry depicts individual differences 
impacting cognitive-behavioral responses to stress via perceived stress and impacting 
physiologic responses to stress directly.    Cognitive-behavioral responses to stress impact 
physiological responses to stress.  Finally, both cognitive-behavioral responses to stress 
and physical responses to stress can lead to disease.   
A review of the literature demonstrated that cancer occurrence (disease), sleep 
(main cognitive-behavioral response to stress of interest), and allostatic load (physiologic 
response to stress) each have been shown to be impacted by individual differences.  
Gender, race, age, income, and education are related to each of these main concepts of 
interest in this proposed study, and therefore need to be included.   
There is evidence that some cognitive-behavioral responses to stress are related to 
cancer.  Alcohol use and smoking are firmly established as cancer risks.  The evidence 
linking physical activity and cancer is weaker, but indicates a relationship is likely.  
Depression and depressive symptoms are frequently comorbid with cancer, but 
depression and future cancer occurrence and depressive symptoms and future cancer 
occurrence are understudied.   
There is evidence that sleep is impacted by other cognitive-behavioral responses 
to stress including alcohol use, smoking, physical activity, and depression.  Relationships 
between allostatic load and cognitive-behavioral responses to stress is scant.  Initial 
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research reports from investigations of allostatic load and alcohol use, smoking, physical 
activity, and depression are mixed.  The findings from the literature review underscore 
the need to include these cognitive-behavioral responses in this investigation.   
As with other cognitive-behavioral factors, a relationship between sleep and 
allostatic load is understudied and the existing evidence is mixed.  Preliminary research 
into allostatic load and diagnoses for sleep disorders demonstrated an increased 
prevalence of elevated allostatic load among people with sleep disorders such as sleep 
apnea and snoring.  Some studies of short sleep duration and allostatic load and long 
sleep duration and allostatic load have found relationships while other studies have not 
identified such links.  Additionally, each of the articles reviewed used a priori definitions 
of short and long sleep duration; none explored the data to identify relevant sleep 
duration cut points.  A single study of subjective sleep quality and allostatic load reported 
a black race-allostatic load relationship was mediated in part by sleep quality (Tomfohr et 
al., 2016).  Further investigation exploring a possible relationship between sleep and 
allostatic load is needed.   
Sleep problems, including subjective sleep quality, disturbed sleep, and insomnia, 
are frequently comorbid with cancer.  Sleep problems are known to occur across the 
cancer care trajectory, from before treatment initiation to survivorship.  There is initial 
evidence that sleep parameters may be related to future cancer occurrence, but this is 
understudied.  Initial evidence links short sleep duration and long sleep duration (as 
compared to healthy sleep) with future cancer occurrence, but studies of sleep duration 
and future cancer varied widely in their operationalization of short and long sleep 
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duration.  As with sleep and allostatic load research, each of the articles of sleep duration 
and future cancer identified used a priori definitions of short and long sleep duration; 
none explored the data to identify relevant sleep duration.  Preliminary evidence shows 
subjective sleep quality may play a role in future cancer, but this remains a largely 
unexplored relationship.   
There is scant evidence of an association between allostatic load and cancer.  
Only two relevant studies were identified in this review.  One cross-sectional study found 
black women with breast cancer had elevated allostatic load using nine biomarkers from 
four allostatic load domains (Parente et al., 2013). One cross-sectional study of Puerto 
Ricans living in Boston did not find a link between allostatic load and prevalent cancer 
using 10 biomarkers from 5 allostatic load domains (Mattei et al., 2010). Both of the 
identified studies examining cancer and allostatic load created an allostatic load 
composite using the sum of a priori clinical definitions of normal/abnormal biomarker 
results, a commonly used method of investigating allostatic load (Mattei et al., 2010; 
Parente et al., 2013). The problem with this approach to analyzing allostatic load is it can 
mask the impact of a particularly relevant biomarker and it fails to account for potential 
interrelationships between each of the biomarkers.  Newer strategies for handling 
allostatic load, such as using structural equation modeling, allow for interactions among 
the indicators and for the impact of subclinical levels of biomarkers to be examined.   
There is initial evidence demonstrating values for some individual biomarkers 
may be worse for people living with cancer, but the available findings mostly do not 
address future occurrence or recurrence of cancer.  A single study of biomarkers and 
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future cancer was identified; researchers reported glucose is related to future cancer 
occurrence (Agnoli et al., 2015).  The available findings are limited by the number of 
relevant studies, by populations studied, and by methodology for allostatic load.  For 
example, it is suspected that inflammation may play a role in cancer development and 
progression (Korneev et al., 2017).  However, of the allostatic load research identified for 
this literature review, inflammatory biomarkers were rarely included, and if inflammatory 
markers were included, it was only a single marker.  Current knowledge of a relationship 
between comprehensive allostatic load and future cancer occurrence is limited and needs 
further investigation.   
Regarding possible associations between cancer, cognitive-behavioral responses 
to stress, and physiologic responses to stress, no studies were identified that directly 
examined the relationship between sleep, allostatic load, and future cancer occurrence.  
As noted above, there is some evidence of a relationship between sleep and future cancer, 
while there is scant knowledge about a link between allostatic load and sleep and 
allostatic load and future cancer.   
The proposed study will help to address the identified gaps in knowledge.  
Longitudinal data from a national sample of middle ages adults will be used to identify 
associations between the concepts of interest and future occurrence of cancer.  Sleep 
measures include sleep duration and several domains of sleep quality, including sleep 
latency, habitual sleep efficiency, sleep disturbance, use of sleep medication, daytime 
dysfunction, and overall sleep quality.  Methods addressing sleep duration will include a 
priori categories of short, normal, and long sleep duration based on sleep duration 
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recommendations from the National Sleep Foundation as well as cut points for short, 
normal, and long sleep duration identified from exploration of the actual data.  Allostatic 
load will be treated as a latent variable measured by observed indicators comprised of 
biomarkers, physical exam measures, and psychophysiological measures, and structural 
equation methods will be used to model the complexity of allostatic load and allow for 
interrelationships between indicators.  The expected knowledge gained in this study will 
illuminate predictors of future cancer occurrence and evaluate the influence of cognitive-
behavioral responses to stress (sleep) and physiologic responses to stress (allostatic load) 
on future cancer.  Findings will provide areas for possible intervention in cancer 
prevention efforts.   
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CHAPTER III 
METHODS 
Purpose 
 The purpose of this study was to identify cognitive-behavioral responses to stress 
and physiological responses to stress that are related to future disease, specifically future 
cancer occurrence.   The primary cognitive-behavioral response to stress studied was 
sleep.  Other cognitive-behavioral factors of interest included depression, physical 
activity, smoking and alcohol use.  The physiologic response to stress studied was 
allostatic load.  Allostatic load is comprised of biomarkers, physical measures, and 
psychophysiologic measures.  Relevant individual differences included in the analysis in 
the context of their relationship to stress responses were age, race, gender, education and 
income.    
Research Questions and Hypotheses 
1. Research Question 1. Is there a relationship between sleep and future cancer 
occurrence among middle-aged adults in the United States? 
 Hypothesis 1.1: Poor self-reported, subjective sleep quality will be associated 
with increased future cancer occurrence.  
 Hypothesis 1.2: Short sleep duration and long sleep duration as compared to 
normal/healthy sleep duration will be associated with increased future cancer occurrence.
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2. Research Question 2. Is there a relationship between allostatic load and occurrence of 
future cancers among middle-aged adults in the United States.? If there is, are there 
physiologic domains that are associated with the occurrence of future cancers? 
 Hypothesis 2.1: Increased allostatic load will be associated with increased 
occurrence of future cancers.   
 Hypothesis 2.2: The inflammation domain, sympathetic nervous system domain, 
and hypothalamic-pituitary-adrenal axis domain will be associated with the occurrence of 
future cancers.   
3. Research Question 3. Is there a relationship between sleep and allostatic load among 
middle-aged adults in the United States? If a relationship exists, are there physiologic 
domains that are associated with sleep?   
 Hypothesis 3.1: Poor self-reported, subjective sleep quality will be associated 
with increased allostatic load.  
 Hypothesis 3.2: Short sleep duration and long sleep duration as compared to 
normal/healthy sleep duration will be associated with increased allostatic load.  
 Hypothesis 3.3:  Poor sleep will be associated with the inflammation domain, 
glucose domain, lipid domain, and cardiovascular domain.   
4. Research Question 4. If a relationship exists between sleep and the occurrence of 
future cancers among middle-aged adults, does allostatic load mediate that relationship?  
 Hypothesis 4.1: Allostatic load will mediate the sleep-future cancer occurrence 
relationship.  
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Methods 
 This study was a secondary analysis of existing data from the Midlife in the 
United States (MIDUS) study.  MIDUS  is a longitudinal study of the health of middle-
aged Americans (“Midlife in the United States, A National Longitudinal Study of Health 
and Well-being,” 2011).  Begun in 1995, there have been three rounds of data collection, 
and more are planned (“Midlife in the United States, A National Longitudinal Study of 
Health and Well-being,” 2011).  In the second wave of data collection (known as MIDUS 
II), a subset of the MIDUS subjects participated in the collection of samples of biological 
samples, underwent a physical exam, and answered detailed questions about their health 
history and habits; this was termed the Biomarker Project.  Data for the Biomarker 
Project was collected from 2004 to 2009.  In the third wave of data collection, updated 
health history was collected from participants, including questions about medical 
problems such as cancer, from 2013-2014; this project is termed MIDUS III.  Details 
about the sampling plan for all MIDUS time points, methods for data collection, 
inclusion and exclusion criteria and other information related to MIDUS research 
procedures can be found on the MIDUS website at http://midus.wisc.edu/ and on the 
Inter-University Consortium for Political and Social Research website where the data is 
housed at https://www.icpsr.umich.edu/icpsrweb/index.jsp.  The original MIDUS sample 
included four subsamples: a national random digit dialing sample, oversamples from five 
large metropolitan cities, siblings of the participants from the random digit dialing 
sample, and a national random digit dialing sample of twin pairs (Brim et al., 2016).  
Samples for subsequent MIDUS waves were derived from this original sample.  MIDUS 
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II added new participants, an oversample of African Americans from Milwaukee (Brim et 
al., 2016).  
Sample 
The sample for this project came from the Biomarker Project of MIDUS II (data 
collection at time one for the current study) and MIDUS III (time two for the current 
study).  A total of 1,255 people participated in the Biomarker Project (C. D. Ryff, 
Seeman, & Weinstein, 2013c).  Subjects who reported having a cancer either on the 
MIDUS II telephone survey or in the MIDUS II Biomarker Project were excluded from 
participating in this study.  Data were then merged with MIDUS III telephone survey 
results for the question “have you ever had cancer”.  Data missing on this question were 
excluded.  A final sample size of 806 participants was used for further analysis.  In this 
sample, there were 78 cases of cancer.  
For analyses utilizing allostatic load, 7 cases missing significant numbers of 
allostatic load indicators were excluded.  Another 5 cases missing significantly on the 
glucose system factor indicators and another 25 cases missing significantly on 
sympathetic system indicators were excluded.  For all analyses involving allostatic load, 
this resulted in a final sample size of 769 that includes 77 cases of cancer.  
Data Collection 
At time one for the proposed study, the existing MIDUS II Biomarker Project data 
collection took place over the course of two days at a data collection center.  Medical 
history, self-administered questionnaire, and the Pittsburgh Sleep Quality Questionnaire 
data were obtained the evening of day one (C. D. Ryff et al., 2013c).  Twelve hour urine 
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collection was initiated the evening of day one (C. D. Ryff et al., 2013c).  The morning of 
day two, 12 hour urine collection was completed, fasting bloodwork was obtained, the 
psychophysiology experiment was conducted, and the short physical exam (vital signs, 
waist and hip measures, functional measures) was conducted (C. D. Ryff et al., 2013c).  
At time two for the proposed study (MIDUS III), cancer diagnosis since time one was 
assessed during a telephone conversation with a trained interviewer.   
Measurement 
Multiple variables and indicators of the conceptual framework were used.  Tables 
1 and 2 provide a list of concepts and variables.   
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Table 1 
 
Concepts of Interest, Conceptual Definitions, and Indicators 
 
Concept of 
Interest 
Conceptual 
Definition 
Indicator Indicator Definition 
Variable 
Measured 
Response Set 
Disease A change from 
normal 
functioning 
that causes 
harm 
Cancer “Uncontrolled growth and 
spread of abnormal cells” 
(National Cancer Institute,  
n.d.-c) 
Self-reported 
history of 
cancer 
Yes/No 
Individual 
differences 
Personal 
characteristics 
and 
experiences 
Age The length of a person’s life in 
years 
Self-reported 
number of 
years of life 
Years 
  Gender/ 
Sex 
Gender as behavioral cultural or 
psychological traits typically 
associated with one particular 
sex, and sex is defined as 
biological characteristic 
determined by a person’s sex 
organs 
Self-reported 
gender 
Male/Female 
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  Race A categorization of humans 
based on select physical 
characteristics, typically skin 
color 
Self-reported 
race 
White/Not white 
 
 
 
 
 Education The highest type of formal 
learning program participated in 
Self-reported 
highest 
education 
level achieved 
- Less than a high school 
diploma 
- High school 
graduate/GED or 
equivalent 
- Some college or AA 
degree 
- College graduate or 
above  
  Income Amount of incoming financial 
resources (whether in dollars or 
some kind of government 
assistance) for respondent’s 
household 
Self-reported 
household 
income 
- <$20,000 
- $20,000-$39,999 
- $40,000-$59,999 
-$60,000-$74,999  
- $75,000 or more 
Cognitive-
behavioral 
responses 
Thoughts, 
reasoning, 
feelings, and 
actions in 
response to 
stimuli 
Sleep “The natural periodic suspension 
of consciousness during which 
the powers of the body are 
restored” (Merriam-Webster, 
2017b).  
Self-reported 
hours of sleep 
duration 
Hours 
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    Subjective 
sleep quality 
Component score 0, 1,  
2, or 3 
    Subjective 
sleep latency 
Component score 0, 1,  
2, or 3 
    Subjective 
sleep duration 
Component score 0, 1,  
2, or 3 
    Subjective 
habitual sleep 
efficiency 
Component score 0, 1,  
2, or 3 
    Self-reported 
sleep 
disturbances 
Component score 0, 1,  
2, or 3 
    Self-reported 
use of sleep 
medication 
 
Component score 0, 1,  
2, or 3 
    Self-reported 
daytime 
dysfunction 
Component score 0, 1,  
2, or 3 
    Subjective 
global sleep 
quality 
Good sleep (5 or 
less)/Poor sleep (>5) 
derived from total score 
of 0 - 21 
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  Alcohol 
Use 
The consumption of alcohol 
containing beverages 
Self-reported 
alcohol use in 
past month 
Any/None 
  Smoking  Use of cigarettes at present or in 
the past 
Self-reported 
cigarette use 
history 
Ever/Never 
  Physical 
Activity 
Participation in active leisure-
time activities that result in 
raised heart rate and sweating 
Self-reported 
exercise (at 
least 20 
minutes 3 
times per 
week) 
Yes/No 
  Depressive 
Symptoms 
Self-reported complaints of 
symptoms commonly associated 
with depression including 
“depressed mood, feelings of 
guilt and worthlessness, feelings 
of helplessness and 
hopelessness, psychomotor 
retardation, loss of appetite and 
sleep disturbance” (Radloff, 
1977, p. 386) 
Self-reported 
depression 
symptom-
ology 
Score of 16 or 
more/score less than 16 
derived from total score 
of 0 - 60 
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Physiologic 
responses          
 
 
 
Biologic 
embodiment of 
reaction to 
stimuli 
Allostatic 
Load 
 
“The wear and tear on the body 
and brain resulting from chronic  
overactivity or inactivity of 
physiological systems that are 
normally involved in adaptation 
to environmental challenge” 
(Bruce S. McEwen, 1998b, p. 
37). 
Please see 
Table 2 
 
 
 
 
 
Table 2 
 
Allostatic Load Component Conceptual Definitions and Indicators 
 
Physiologic domain Conceptual Definition Indicator Indicator Definition 
Variable 
Measured 
Sympathetic nervous 
system 
One branch of the 
autonomic nervous 
system that is 
responsible for the 
fight-or-flight stress 
response 
Norepinephrine A hormone involved in the body’s 
response to stress. Its actions on the 
body include increasing blood 
pressure, increasing blood flow to the 
heart and relaxation of intestinal 
muscles (“Noradrenaline,” 2014).   
12 hour 
urinary 
norepinephrine 
(ng/mL) 
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  Epinephrine A hormone involved in the body’s 
acute response to stress.  Its actions on 
the body include increasing heart rate, 
increasing respiratory rate, slowing 
blood flow to the digestive tract, and 
increasing metabolism (“Adrenaline,” 
2014).  
12 hour 
urinary 
epinephrine 
(ng/mL) 
 
Parasympathetic 
nervous system 
One branch of the 
autonomic nervous 
system that is 
responsible for the 
body’s unconscious 
functions that occur at 
rest, such as salivation 
and digestion 
Standard 
deviation of 
beat to beat 
intervals (HRV) 
The standard deviation of the distance 
between each heart beat recorded by an 
electrocardiograph (EKG) (Allen, 
Chambers, & Towers, 2007). 
 
  Root mean 
square of 
successive 
differences of 
beat to beat 
intervals (HRV) 
The square root of the mean of squared 
successive differences of the distance 
between each heart beat recorded by an 
EKG (Allen et al., 2007). 
 
  Low frequency 
heart rate 
variability 
The number of low frequency (0.04-
0.15 Hz) bands in beat-to-beat intervals 
that have been transformed into 
frequency (Allen et al., 2007). 
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  High frequency 
heart rate 
variability 
The number of high frequency (0.15-
0.50 Hz) bands in beat-to-beat intervals 
that have been transformed into 
frequency (Allen et al., 2007). 
 
  Heart rate Heart rate is the number of beats per 
minute. 
 
Hypothalamic-
pituitary-adrenal axis 
A system of complex 
endocrine interactions 
involving the 
hormones from the 
hypothalamus, 
pituitary, and adrenal 
endocrine glands; is 
influenced by the 
experience of stress; is 
involved in regulating 
many other 
physiologic systems 
Cortisol A hormone used in metabolism and in 
response to stress.  
12 hour 
urinary 
cortisol 
(ug/dL) 
 
  DHEAS A hormone produced by the adrenal 
glands thought to play a role in aging 
serum DHEAS 
(ug/dL) 
 
Inflammation Cellular level reaction 
to injury 
C reactive 
protein 
A protein associated with infections 
and inflammation (“C-reactive 
protein,” 2014).   
serum CRP 
(ug/mL) 
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  Interleukin 6 A protein involved in immunity that 
has both pro-inflammatory and anti-
inflammatory actions and is thought to 
play a role in cancer development and 
progression (Korneev et al., 2017).   
serum IL6 
(pg/mL) 
 
  Fibrinogen A coagulation factor that has pro-
inflammatory actions and is associated 
with cancer (“Fibrinogen,” 2014; 
Davalos & Akassoglou, 2012).   
serum 
fibrinogen 
(mg/dL) 
 
  Soluble E-
selectin 
Acellular adhesive molecule associated 
with inflammation that also appears to 
play a role in cancer 
serum E-
selectin 
(ng/mL) 
 
  Soluble 
intracellular 
adhesion 
molecule 1 
A cellular adhesion molecule 
associated with inflammation. 
serum ICAM-
1 
(ng/mL) 
 
Cardiovascular  Systolic BP The pressure exerted on artery walls 
during systole (“Blood pressure,” 
2014). 
systolic BP 
(mmHg) 
 
  Pulse Pressure Calculated difference between systolic 
blood pressure reading and diastolic 
blood pressure reading. 
pulse pressure 
(mmHg) 
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Glucose  Glucose A simple sugar whose blood levels are 
maintained by hormones such as 
insulin and glucagon (“Glucose,” 
2014). 
serum glucose 
(mg/dL) 
 
  Glycated 
hemoglobin  
A form of hemoglobin with a molecule 
of glucose attached; the percent of 
hemoglobin that is glycated depends on 
blood levels of glucose (“Glycated 
haemoglobin,” 2014).   
serum HbA1c  
(%) 
 
  Homeostatic 
model of insulin 
resistance  
A calculated measure of insulin 
resistance based on fasting glucose and 
fasting insulin (Matthews et al., 1985).     
calculated 
HOMA-IR 
Lipid  Waist to hip 
ratio  
A measure of obesity calculated from 
the circumference of the waist and the 
hips (“Waist to hip ratio,” 2016). 
waist and hip 
circumference 
  High-density 
lipoprotein  
A protein that transports cholesterol in 
the body and helps to remove 
cholesterol from the bloodstream 
(“High-density lipoprotein,” 2016).   
serum HDL 
(mg/dL) 
 
  Low-density 
lipoprotein 
The main protein involved in 
transporting cholesterol in the 
bloodstream (“Low-density 
lipoprotein,” 2016).   
calculated 
LDL 
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  Triglycerides Glycolipids made up of glycerol and 
three fatty acids and are the manner in 
which digested fat is transported in the 
bloodstream (“Triglyceride,” 2016). 
serum 
triglycerides 
(mg/dL) 
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The discussion below explains details of measurement in the original data collection and 
differences in the present study.  
Outcome of interest.  Cancer diagnosis at time two was assessed with a single 
question “have you ever had cancer?” via telephone interview.  Reponses were recorded 
as a dichotomous “yes” or “no”.   
Cognitive-behavioral responses to stress.  Cognitive-behavioral responses to 
stress were obtained at time one. Information on sleep quality was measured by the 
Pittsburgh Sleep Quality Index (PSQI), a commonly used subjective measure of sleep 
quality (Buysse, Reynolds, Monk, Berman, & Kupfer, 1989).  This was collected at time 
one.  The PSQI has been shown to be a reliable and valid measure of sleep quality, with a 
Cronbach’s alpha coefficient ranging from 0.70 to 0.83 (Mollayeva et al., 2016).  The 
PSQI is a 19-item measure with content in seven domains: subjective sleep quality, sleep 
latency, sleep duration, habitual sleep efficiency, sleep disturbance, use of sleeping 
medications, and daytime dysfunction (Buysse et al., 1989). Respondents are asked to 
answer the PSQI questions in relation to their experience of sleep in the past month 
(Buysse et al., 1989).  Results for each domain are calculatedly separately, and an overall 
global score of sleep quality is calculated from the sum of the seven domains (Buysse et 
al., 1989).  Total PQSI scores can range from 0 to 21, and possible domain scores range 
from 0 to 3 (Buysse et al., 1989).  Higher scores on the individual PQSI domains indicate 
poorer sleep quality (Buysse et al., 1989).  Per PSQI scoring instructions, total global 
PSQI is a binary variable, and participants whose sum of the seven sleep domain scores is 
5 or more are considered to have poor sleep quality, while participants’ scores of 5 or less 
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are considered normal sleep quality.  In the current study, each of the individual domains 
as well as the global score of sleep quality were examined in relation to future cancer and 
allostatic load.  The sleep efficiency domain calculated the difference between total time 
spent in bed and time spent asleep in bed.  Thirty-eight cases reported a time asleep in 
bed greater than 100% of the total time in bed, but this is not possible. The global score 
for PSQI for these 38 cases was not calculated and left as missing data.  The PSQI 
domain of sleep duration defines normal sleep as 7 hours per night or more; the other 
categories of sleep are 6-7 hours per night, 5-6 hours per night, and <5 hours per night 
(Buysse et al., 1989).   
In the current study, additional variables defining sleep duration were examined in 
relation to future cancer occurrence and allostatic load.  Sleep duration was treated as a 
continuous variable in hours as well as transformed into a categorical variable (short, 
normal, or long sleep).  Both short sleep duration and long sleep duration were compared 
to normal sleep as the reference group.  As there is no clear consensus in the literature 
about what constitutes short sleep duration and long sleep duration in relation to future 
cancer, sleep recommendations for adults from the National Sleep Foundation (NSF) 
were used to determine a priori categorizes for sleep duration.  The NSF recommends 7 
to 9 hours of sleep per night for adults aged 18 to 64, and 7 to 8 hours of sleep per night 
for adults 65 and older (Hirshkowitz et al., 2015b).  However, the distribution of the data 
showed few participants sleeping more than 9 hours per day.  As 7 to 8 hours of sleep per 
night is also considered normal for all adults 18 years and older, the decision was made to 
stratify sleep hours based on 7 to 8 hours as normal sleep.  NSF sleep duration categories 
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were dummy coded into short (<7 hours of sleep per night), normal or referent (7-8 hours 
of sleep per night), and long sleep duration (>8 hours of sleep per night).  Finally, the 
data were explored for relevant sleep duration categories based on cancer diagnosis in the 
future.  A Chi-squared Automatic Interaction Detector (CHAID) decision tree in SPSS 
was used to identify categories of sleep duration based on future cancer occurrence.  The 
CHAID decision tree examined data inputs to identify categorical cut points that 
minimize p-values. Results were dummy coded into short, normal (or referent), and long 
sleep duration categories.  
Physical activity level was assessed with a single item.  Participants were asked 
“do you engage in regular exercise, or activity, of any type for 20 minutes or more at 
least 3 times/week?” (C. Ryff et al., 2012c).  Responses were recorded dichotomously as 
“yes” or “no”.  Assessing physical activity via self-report is a commonly used 
measurement method (Sylvia, Bernstein, Hubbard, Keating, & Anderson, 2014).  
Smoking status was a binary variable that denoted which subjects have ever smoked 
versus those that have never smoked (C. Ryff et al., 2012c).  This is a standard 
measurement of assessing smoking status prevalence (Global Adult Tobacco Survey 
Collaborative Group, 2011).    Alcohol use was assessed in the MIDUS Biomarker 
Project by asking how often alcoholic beverages were consumed on an average basis over 
the past month (C. Ryff et al., 2012c).  For the current study, ordinal level responses 
ranging from every day to never were collapsed into a binary variable: any alcohol 
consumption in the past month versus no alcohol use in the past month.  Measures of 
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self-reported alcohol use have been commonly used and were generally accurate (Sobell 
& Sobell, 2004).   
Depressive symptoms were assessed using the Center for Epidemiological Studies 
Depression Inventory (CESD).  The CESD is a commonly used measure of depressive 
symptoms with established reliability and validity in numerous populations as well the 
general population (Devins et al., 1988; Radloff, 1977; Roberts & Vernon, 1983).  The 
Cronbach’s alpha of the CESD in the general population ranges from 0.84 to 0.90 
(Radloff, 1977).  The CESD depression scale is comprised of 20 items assessing the 
experience of depressive symptoms over the past week (Radloff, 1977).  Four of the 
items are stated in such a way as to not reflect depressive symptoms and must be reverse 
coded (Radloff, 1977).  Then the number of affirmative answers are summed to give a 
total score that can range from 0 to 20 (Radloff, 1977).  Higher scores indicated a greater 
number of depressive symptoms (Radloff, 1977).  For the current study, depressive 
symptoms were transformed into a binary variable based on a cutoff score of 16 on the 
CESD; scores of 16 or more indicate probable clinical depression (Beekman et al., 1997; 
Lewinsohn, Seeley, Roberts, & Allen, 1997).   
Physiologic response to stress.  Physiologic response to stress was assessed at 
time one.  Allostatic load was comprised of biomarkers, physical measures, and 
psychophysiologic measures from multiple physiologic systems obtained at time one.  
These measures are divided amongst seven physiologic domains of allostatic load as 
specified in Wiley et al (2016).  The physiologic domains used in this study were 
sympathetic nervous system, parasympathetic nervous system, hypothalamic-pituitary-
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adrenal axis, inflammation, cardiovascular, glucose, and lipid domains.  Please see Table 
2 for a complete list of domains and their associated measures.   
 Biomarkers.  Three measures of serum lipids were used, including high-density 
lipoprotein (HDL), triglycerides (TG), and low-density lipoprotein (LDL).  Low density 
lipoprotein (LDL) was a calculated variable from total cholesterol, HDL and TG using 
the Fridewald formula (LDL = TC-HDL-TG/5) (C. D. Ryff, Seeman, & Weinstein, 
2013a).  The LDL calculation is unreliable if TG are greater than 400 mg/dL, therefore 
400 mg/dL was the value used for TG in the calculation of LDL (C. D. Ryff et al., 
2013a).  Additionally, extreme results from cholesterol testing that were altered.  If HDL 
was greater than 120 mg/dL, it was truncated to 121 mg/dL regardless of value (C. D. 
Ryff et al., 2013a).  Subsequently, calculations for LDL were made used this altered 
value of HDL (C. D. Ryff et al., 2013a).  For the three measures of serum lipids were 
used as continuous variables.  
 Measures of inflammation were serum C-reactive protein (CRP), interleukin 6 
(IL6), fibrinogen (FG), soluble E-selectin (ES), and soluble intracellular adhesion 
molecule-1 (ICAM-1).  CRP is a protein associated with infections and inflammation 
(“C-reactive protein,” 2014).  IL6 is a protein involved in immunity that has both pro-
inflammatory and anti-inflammatory actions and is thought to play a role in cancer 
development and progression (Korneev et al., 2017).  FG is a coagulation factor 
(“Fibrinogen,” 2014).  It also has pro-inflammatory actions and is associated with cancer 
(Davalos & Akassoglou, 2012).  ES is a cellular adhesive molecule associated with 
inflammation that also appears to play a role in cancer (Natoni, Macauley, & O’Dwyer, 
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2016).  ICAM-1 is a cellular adhesion molecule associated with inflammation (Dowd, 
Goldman, & Weinstein, 2011).  Extreme results for inflammatory markers were altered.  
CRP results less than 0.15 ug/dL or less than 0.16 ug/dL were reported as 0.14 ug/dL (C. 
D. Ryff et al., 2013a).  ES results less than 0.1 ng/mL were reported as 0.09 ng/mL (C. D. 
Ryff et al., 2013a).  ICAM-1 results less than 45 ng/mL were reported as 44 ng/mL (C. D. 
Ryff et al., 2013a).  For the current study, CRP, IL6, FG, ES, and ICAM-1 are continuous 
variables.  
 Glucose is a simple sugar whose blood levels are maintained by hormones such as 
insulin and glucagon; high levels are associated with diabetes (“Glucose,” 2014).   
Glycated hemoglobin (HbA1c) is a form of hemoglobin with a molecule of glucose 
attached (“Glycated haemoglobin,” 2014).  The percent of hemoglobin that is glycated 
depends on blood levels of glucose (“Glycated haemoglobin,” 2014).  Percent HbA1c 
was calculated by dividing the concentration of HbA1c by the total concentration of 
hemoglobin (C. D. Ryff et al., 2013a).  Homeostatic model of insulin resistance (HOMA-
IR) is a calculated measure of insulin resistance based on fasting glucose and fasting 
insulin (Matthews et al., 1985).  HOMA-IR was calculated by multiplying fasting glucose 
by insulin and then dividing the result by 405 (C. D. Ryff, Seeman, & Weinstein, 2013e).  
Glucose, HbA1c, and HOMA-IR are continuous variables.  
Cortisol is a hormone used in metabolism and in response to stress (“Cortisol,” 
2014).  There was variability in the minimum amount of cortisol detectable by the assay 
for 12-hour urinary cortisol over the duration of data collection (C. D. Ryff et al., 2013a).  
To handle this, all cortisol levels reported with a “<” sign were recorded as 0.019 ug/dL 
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(C. D. Ryff et al., 2013a).  Dihydroepiandrosterone sulfate (DHEAS) is a hormone 
produced by the adrenal glands thought to play a role in aging (Allolio, Arlt, & Hahner, 
2012).  Extreme DHEAS results were altered.  DHEA-S results less than 1 ug/dL were all 
reported as 0.9 ug/dL (C. D. Ryff et al., 2013a).  For the current study, both the 12-hour 
urinary cortisol and serum DHEAS variables were continuous.  
 Epinephrine and norepinephrine are hormones involved in the body’s acute 
response to stress.  Extreme results from catecholamine testing were altered.  Urinary 
epinephrine results less than 0.05 ng/mL were recorded as 0.09 ng/mL (C. D. Ryff et al., 
2013a).  Overnight 12-hour urinary norepinephrine and epinephrine were continuous 
variables and the latter was truncated.  
Physical exam measures.  Systolic blood pressure (SBP) was measured in 
accordance with standard practices three times consecutively with a maximum of 30 
seconds between each measurement (Centers for Disease Control and Prevention, 2017d; 
C. D. Ryff, Seeman, & Weinstein, 2013b).  An average of the three SBP measurements 
reported in mm Hg was used in this study.  Pulse pressure was a calculated variable 
derived from the difference between average SBP from 3 measurements and average 
diastolic blood pressure from 3 measurements.  Waist-hip ratio (WHR) was a calculated 
variable obtained from the measurement of the subject’s waist divided by the 
measurement of the subject’s hips (Harvard T.H. Chan School of Public Health, 2012; C. 
D. Ryff et al., 2013b, 2013e).  For the current study, SBP, pulse pressure, and WHR were 
continuous variables.  
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Psychophysiology measures.  Measures of heart rate variability were calculated 
from an EKG obtained while seated, at rest, over several minutes (C. D. Ryff, Seeman, & 
Weinstein, 2013d).  Heart rate variability at rest is governed by the parasympathetic 
nervous system (Allen, Chambers, & Towers, 2007).  Resting heart rate was calculated as 
an average of all RR intervals and was converted from RR intervals into beats per minute 
(C. D. Ryff et al., 2013d).  Two time-domain measures of heart rate variability will be 
used, the standard deviation of RR intervals (the standard deviation of the distance 
between each heartbeat, (SDRR)), and the root mean squared successive differences (the 
square root of the mean of squared successive differences of the distance between each 
heartbeat (rMSSD)).  Two frequency-domain measures of heart rate variability were 
used, heart rate variability in the low frequency (LFHRV) and high frequency (HFHRV).  
LFHRV is the number of low frequency bands (0.04-0.15 Hz) in beat-to-beat intervals 
that have been transformed into frequency (Allen et al., 2007; C. D. Ryff et al., 2013d).  
HFHRV is the number of high frequency bands (0.15-0.50 Hz) in beat-to-beat intervals 
that have been transformed into frequency (Allen et al., 2007; C. D. Ryff et al., 2013d).  
For the current study, resting heart rate, SDRR, rMSSD, LFHRV, and HFHRV were 
continuous variables.  
Individual differences.  Individual differences were assessed at time one.  Age 
was treated as a continuous variable measured in years, and MIDUS defined age as a 
person’s age in years as of his or her last birthday (C. Ryff et al., 2012a).  Gender of 
respondent was coded dichotomously as male or female.  Race was assessed during the 
telephone interview by giving subjects a list of choices after asking subjects “which best 
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describes your race?” (C. Ryff et al., 2012d).  For the current study, due to limitations in 
the sample composition, race was dichotomized into white versus not white.  Education 
level was assessed in the telephone interview by asking respondents “what’s the highest 
grade of school or year of college you completed?” (C. Ryff et al., 2012d).  MIDUS 
utilizes 12 categories of education level (C. Ryff et al., 2012d).  For the current study, 
educational level categories were collapsed into the four ordinal categories based on the 
National Health and Nutrition Examination Survey (NHANES) categories: less than a 
high school diploma, high school graduate/GED or equivalent, some college or AA 
degree, and college graduate or above (Centers for Disease Control and Prevention, n.d.).  
Income reflected the total annual income in dollars for a subject’s household including 
income from wages, pensions, social security and government assistance (C. Ryff et al., 
2012d).  For the current study, continuous income was collapsed into five ordinal 
categories based on the NHANES income categories: <$20,000, $20,000-$39,999, 
$40,000-$59,999, $60,000-$74,999, and $75,000 or more (Centers for Disease Control 
and Prevention, n.d.) 
Time.  Although the preferred time metric was the duration of time between 
assessment of sleep parameters and allostatic load at time one and time to cancer 
diagnosis (or time to assessment of cancer status at time two for those participants 
without cancer), limitations in the data did not allow for this.  Therefore, the time variable 
in this study used for analysis was the number of years between time one and time two.   
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Statistical Analysis 
 Exploratory data analysis was conducted in SPSS version 25 to examine data for 
its distribution, missing values and outliers, and multicollinearity (IBM Corp, 2017).  
There were three biologically implausible values for waist-to-hip ratio; these were 
changed to missing.  Many of the indicators for allostatic load had extreme outliers.  
These were biologically plausible, but strongly impacted the distribution of the data.  To 
address this, the upper and lower 0.5% of values for each indicator of allostatic load were 
Winsorized. 
All variables in the data were checked for multicollinearity and no 
multicollinearity was found that would indicate inflated test statistics. The highest 
variance inflation factor found was for the HPA system at 3.10 (O’Brien, 2007).  
Correlation with cancer status at time 2 was assessed for all the variables of interest and 
none were found to be strongly correlated with cancer.  Next, correlation with overall 
allostatic load and each of the seven domain-specific factor scores was assessed for all 
the variables of interest.  There were weak correlations between depressive symptoms 
and the global PSQI score (0.36), between depressive symptoms and the daytime 
dysfunction domain of the PSQI (0.32), and between the HPA system and age (-0.43).  
The only moderate strength correlation identified was between overall allostatic load and 
gender (alpha was -0.58).  The data for gender were coded as 1 for male and 2 for female, 
therefore a negative correlation indicates a potential association between male gender and 
allostatic load.  In addition to analyzing the entire sample for a relationship between 
cancer and allostatic load, the data were stratified by gender and analyzed separately.   
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Power was calculated for research question 1 using G*Power (Faul, Erdfelder, 
Buchner, & Lang, 2009).  Based on a hypothesized odds ratio of 1.5, an of 0.05, and 
power of 0.8, the needed sample size is 709. Research questions 2, 3, and 4 which 
examine relationships between sleep (cognitive-behavioral response to stress), allostatic 
load (physiologic response to stress), and future occurrence of cancer (disease) were 
addressed via confirmatory factor analysis (CFA) due to the complex nature of the 
allostatic load concept.  Power was estimated for the CFA analysis using McCallum et 
al’s (1996) tables for power and sample size estimation in structural equation modeling.  
The estimated power for a sample size of 500 in a model with poor fit is 0.982 
(MacCallum et al., 1996).  As the sample size including allostatic load is 769, there was 
acceptable power in this analysis.   
Initial exploration of the data included bivariate logistic regressions performed for 
cancer on every variable under consideration.  Among the indicators of individual 
differences and cognitive-behavioral responses to stress other than sleep, the only 
significant relationship was found between age and future cancer.  The odds of a future 
cancer occurring increase by 4% for each increase in age of one year.  Relationships 
between future cancer and variables for gender, race, education, income, depressive 
symptoms, smoking status, alcohol use in past month, and physical activity were not 
found.  Despite these null findings, since the conceptual framework specifically includes 
a number of factors for individual differences and cognitive-behavioral responses to 
stress based on existing evidence about relationships among these concepts, the decision 
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was made to proceed with analysis using all variables of interest rather than pursuing 
more parsimonious models at this time.   
Even beyond the sibling relationships in the sample, the sampling strategy for the 
original MIDUS data was not random.  In addition to sampling via random digit 
telephone dialing, some twin pairs and sibling groups were included, and African 
Americans, older Americans, and men were oversampled.  MIDUS had calculated post-
stratification using the Current Population Study from the Census Bureau sample weights 
for approximately half of the sample for the present study (C. Ryff et al., 2012b).  Based 
on the sample weight calculations available for part of the sample of the current study, 
and in consideration of the MIDUS sample methods, bias, and overrepresentation, age, 
race, and gender were determined to be impactful to the present study.  To account for 
these sampling issues, age, race, and gender, plus an interaction term of age X race X 
gender were included in every multivariate model.   
Research question 1 examining sleep (cognitive-behavioral response to stress) and 
future cancer occurrence (disease) was addressed via logistic regression using Stata 
version 15 (StataCorp, 2017).  The data were complex in that some participants in the 
sample are siblings from the same family and some of these are twin pairs.  A solution to 
handling clustered sampling is using robust standard error estimating in analysis and 
accounting for the relationship amongst siblings.  Additionally, there were only 
approximately 10% cancer cases in the data, causing concern for small sample bias 
(systematic error) in logistic regression.  A solution that accounts for small sample bias 
was to use penalized maximum likelihood estimation, also called the Firth method (Firth, 
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1993).  Unfortunately, it was not possible to both account for sibling groups in the data 
and to account for small sample bias impact on the error terms.  To determine the best 
analytic method, logistic regression, logistic regression using a cluster-robust standard 
error estimator, and logistic regression using penalized maximum likelihood estimation 
were performed for each model of cancer on a sleep parameter. Based on comparisons of 
the standard error terms, there were few substantial differences between the model using 
logistic regression and the model using logistic regression with a cluster-robust standard 
error estimator.  However, there were some instances where the standard error using 
penalized maximum likelihood estimation differed greatly from the other two.  Therefore, 
the decision was made to proceed with analysis using Firth’s penalized maximum 
likelihood estimation method.  
The first step in answering research questions 2-4 was calculating allostatic load.  
Numerous methods of handling allostatic load and its associated indicators have been 
used over the years.  This project utilized a recent allostatic load computation using 
confirmatory factor analysis (CFA) to generate the bifactor model for allostatic load as 
was validated by Wiley et al (2016).  With this method, indicators were first loaded onto 
their appropriate physiologic domain (Wiley et al., 2016).  Physiologic domains 
identified by Wiley et al (2016) are sympathetic nervous system, parasympathetic 
nervous system, hypothalamic-pituitary-adrenal axis, inflammation, cardiovascular, 
glucose, and lipid.  Physiologic domains were allowed to co-vary with each other (Wiley 
et al., 2016).  Next, in addition to loading on the appropriate physiologic domain, 
biomarkers loaded onto a second factor, a common factor for allostatic load.  This 
 
 
 81 
method was chosen as Wiley et al (2016) demonstrated biomarkers are both physiologic 
domain-specific and also share a common underlying process of allostatic load.   
Allostatic load indicator data were checked for normality in SPSS prior to 
performing CFA.  Natural log transformations of urinary norepinephrine, urinary 
epinephrine, R-R interval standard deviation, root mean square of successive differences, 
low-frequency power, high-frequency power, urinary cortisol, DHEAS, CRP, IL-6, E-
selectin, glucose, HOMA-IR, glycosylated hemoglobin, and triglycerides were 
performed.  Despite transformations, some indicators remained not normally distributed.  
To account for this, maximum likelihood estimation using robust standard errors was 
used. CFA was conducted in MPlus version 8 (Muthén & Muthén, 1998).  Example 
Mplus syntax used by Wiley et al (2016) was from the Score-project website and served 
as a template for this analysis (Wiley, 2015). 
After the CFA for allostatic load was completed, standardized physiologic domain 
factor scores and overall allostatic load factor scores were exported and used to examine 
the relationships between sleep and allostatic load, and allostatic load and future 
occurrence of cancer (research questions 2 and 3).  Allostatic load factors were examined 
for normality and found to have an approximately normal distribution.   
Research question 2 was addressed using logistic regression in Stata to evaluate 
the relationship between allostatic load and future cancer (StataCorp, 2017).  As with the 
analysis for research question 1 above, the data clustered within sibling groups or twin 
pairs and the potential for small sample bias given the small number of cancer cases were 
cause for concern.  It was not possible to both account for sibling groups in the data and 
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to account for small sample bias impact on the error terms.  As with research question 1, 
results for bivariate regressions using regular logistic regression, logistic regression using 
a robust standard error estimator, and logistic regression using penalized maximum 
likelihood estimation (the Firth method) were compared.  Based on comparisons of the 
standard error terms, there were few substantial differences between the model using 
logistic regression and the model using logistic regression with a cluster-robust standard 
error estimator. However, there were some instances where the standard error using 
penalized maximum likelihood estimation differed greatly from the other two.  Therefore, 
the decision was made to proceed with analysis using Firth’s penalized maximum 
likelihood estimation. 
Research question 3 was addressed in Stata (StataCorp, 2017).  As the allostatic 
load factor scores were approximately normal, linear regression with robust standard 
error estimation was used to examine the data for relationships among sleep parameters 
and allostatic load and physiologic system scores.   
Finally, the possibility of allostatic load functioning as a mediator in the sleep-
future cancer relationship was explored.  Mediation analyses were performed using 
PROCESS version 2.16 by Andrew Hayes, a macro developed to perform mediation and 
moderation analyses (Hayes, 2018).  This analysis is somewhat limited in that the 
PROCESS macro is not able use logistic regression accounting for a clustered sample or 
the effects of small sample bias, two issues in the MIDUS data, therefore interpretation 
has limitations.   
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Assumptions 
A number of assumptions were made in this study.  As it was a secondary 
analysis, it was assumed that the original data were collected using accurate and 
appropriate measures and proper equipment, and that assays were done correctly on 
properly calibrated equipment. It was further assumed that calculated variables are 
computed correctly.  With regard to allostatic load, this study assumed that variables 
comprising allostatic load are appropriate and reflect cumulative wear on the body in 
response to stress.  This study assumed that measures of cognitive-behavioral responses 
to stress and physiologic responses to stress obtained at a single moment in time were 
reflective of usual patterns for subjects (i.e. high allostatic load at data collection likely to 
be associated with chronic high allostatic load and that poor sleep was likely to be 
associated with sleep problems of a long duration). Lastly, it was assumed that all 
humans experience stress.   
Human Subjects Protection 
 After the dissertation committee approved this project, application to the UNC-
Greensboro IRB was made.  The UNC-Greensboro IRB made the determination that this 
study does not constitute human subjects research and IRB approval was not required.  
The original MIDUS data is available via the Inter-university Consortium for Political 
and Social Research (ICPSR) to member institutions, of which UNC-Greensboro is a 
member.  ICPSR is a repository of more than 7000 data collections (“Inter-university 
Consortium for Political and Social Research,” 2016).  The data used for this project are 
publicly available on the ICPSR website and do not contain any identifying information 
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that might lead to the standard or deductive identification of individual subjects.  As such, 
data were stored on a UNC-Greensboro cloud server and for access by the student 
investigator and committee members.  
Summary 
 This study used secondary longitudinal data among middle-aged Americans to 
examine links between subjective sleep quality and self-reported sleep duration and 
future cancers, for links between allostatic load and future cancers, and for links between 
sleep quality and sleep duration, allostatic load, and future cancer occurrence.  Multiple 
cognitive behavioral responses to stress, physiological responses to stress, individual 
difference and cancer occurrence were used. Multiple methods of analysis were used to 
include the original data collection measures, to truncate or categorize measures, and to 
attenuate the sample bias and oversampling impact on findings. In addition, a validated 
modeling method for allostatic load was used. The sample size provided ample power for 
the study. 
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CHAPTER IV 
RESULTS 
 The following reports on the findings from analysis of sleep duration, subjective 
sleep quality, overall allostatic load and seven physiologic domains, and future cancer 
occurrence.  A description of the sample and results by research question are provided.   
Description of the Sample 
In a sample of middle aged and older adults who reported being cancer-free at 
time one, approximately 10% reported cancer at time two.  Slightly more of the subjects 
were female (54%) than male (46%).  The average age was 56.2 years, and age ranged 
from 35 to 86 years.  The sample was racially homogeneous, with fewer than 8% 
reporting a race other than white.  Over half of the sample reported a household income 
of $60,000 or more.  Only 11.4% reported a household income of less than $20,000.  
Similarly, participants were educated, with almost half of the sample reporting a college 
degree or higher.  Slightly more than half of the sample had never smoked.  In the past 
month, one-third of subjects reported they had not consumed any alcohol.  Overall, 
participants in the sample were physically active.  Close to 80% reported exercising for at 
least twenty minutes 3 times per week.  Twelve percent of the sample reported significant 
depressive symptoms.  Ninety percent of the sample had 5 to 9 years between data 
collection times one and two; the median time between data collection time points was 6 
years.  Please see Table 3 for sample characteristics.  Descriptive statistics for the sample
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of n=806 and the sample of N=769 (used in analyses involving allostatic load) were  
 
compared and no substantial differences in the two groups were identified.   
 
 
Table 3 
 
Sample Characteristics 
 
 Mean (SD) or Percent range # missing 
Age 56.2 (10.6) 35-86 0 
Gender   0 
% male 46%   
% female 54%   
Race   2 
% white 92%   
% not white 7.7%   
Income   18 
<$20,000 11.4%   
$20,000-39,999 14.9%   
$40,000-59,999 18.9%   
$60,000-74,999 12.3%   
$75,000 or more 42.5%   
Education   2 
< High School 3%   
High School 21%   
Some College 29%   
>/= College Degree 47%   
Smoking status   1 
Never Smoker 56.8%   
Ever Smoker 43.2%   
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Alcohol in past month   0 
Never 33%   
Ever 67%   
Physical Activity (20 minutes 3x/week)   0 
% Yes 79%   
% No 21%   
CESD Depressive symptoms 7.51 (7.67) 0-49  
CESD Depression (% 16 or greater) 12%  3 
Years between time 1 and time 2 6.29 (1.37) 3-9 0 
Cancer reported at time 2    
% Yes 9.7%   
% No 90.3%   
Note. N=806. SD is standard deviation. CESD is Center for Epidemiologic Studies 
Depression Scale.   
 
 
Sleep Parameters 
 
The number of hours of sleep per day averaged 6.9 and ranged 3 to 11.  Mean 
overall global PSQI score was 5.76 and ranged from 0 to 18.  Forty-five percent of 
respondents were categorized as having poor sleep global sleep quality.  The NSF 
recommends 7 to 9 hours of sleep per night for adults aged 18 to 64, and 7 to 8 hours of 
sleep per night for adults 65 and older (Hirshkowitz et al., 2015a).   However, the 
distribution of the data showed few participants sleeping more than 9 hours per day.  As 7 
to 8 hours of sleep per night is also considered normal for all adults 18 years and older, 
the decision was made to stratify sleep hours into short, normal, and long sleep duration 
based on 7 to 8 hours as normal sleep for the a priori sleep duration categories.  With this 
 
 
 88 
stratification, half of participants reported a normal sleep duration, and around 9% had 
long sleep duration.  Please see Table 4.  
 
Table 4 
 
Descriptive Statistics for Sleep Parameters 
 
Variable Mean (SD) or percent range # missing 
Global PSQI 5.76 (3.35) 0-18 40 
    Global PSQI >5 (%) 45.3%   
Sleep quality 0.97 (0.71) 0-3 1 
Sleep latency 0.83 (0.88) 0-3 9 
Sleep duration 0.79 (0.74) 0-3 3 
Sleep efficiency 0.66 (1.14) 0-4 3 
Sleep disturbances 1.26 (0.55) 0-3 3 
Sleep medication use 0.55 (1.04) 0-3 1 
Daytime dysfunction 0.79 (0.66) 0-3 1 
Hours of Sleep - continuous 6.9 (1.10) 3-11 3 
NSF sleep duration categories    
    <7 hours (short) 41.5%   
    7-8 hours (normal) 49.3%   
    >8 hours (long) 9.2%   
Sleep duration identified from data    
    <5.3 hours (short) 8.5%   
    5.3-7.5 hours (normal) 67.4%   
    >7.5 hours (long) 24.1%   
Note. PSQI is Pittsburgh Sleep Quality Index.  NSF is National Sleep Foundation.  
SD is standard deviation 
 
 
The data were explored for relevant sleep duration categories based on the 
variable for cancer diagnosis in the future.  A Chi-squared Automatic Interaction 
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Detector (CHAID) decision tree in SPSS was used to identify categories of sleep duration 
based on the future cancer occurrence variable.  A CHAID decision tree examines data 
inputs to identify categorical cut points that minimize p-values.  This analysis yielded a 
short sleep duration category of less than 5.3 hours per night, a normal sleep duration of 
5.3 to 7.5 hours per night, and a long sleep duration category of greater than 7.5 hours per 
night.  In these sleep duration categories, 8.5% had short sleep duration, 67.4% had 
normal sleep duration, and 24.1% had long sleep duration.  Please see Table 4.  
Research Question 1 Results 
 
Figure 2 
 
Model of Sleep-Future Cancer Occurrence 
 
 
 
 
Sleep and Future Cancer Occurrence  
 
Research Question 1 pertained to investigating a relationship between sleep and 
future cancer occurrence.  It was hypothesized that poor self-reported sleep quality would 
be associated with future cancers.  To explore a possible relationship between subjective 
sleep quality and future cancer occurrence, cancer status at time two was analyzed with 
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the global PSQI and each PSQI domain subscore.  Initially, bivariate logistic regressions 
were performed for cancer on sleep quality using logistic regression, logistic regression 
with a robust standard error estimator, and logistic regression using penalized maximum 
likelihood estimation (the Firth method).  Please see Table 5 for results.  As noted in 
Chapter III, the Firth method was chosen due to the impact of the small number of cancer 
cases on the data.  No significant relationship was found between any sleep quality 
parameter from the PSQI and future cancer occurrence in bivariate logistic regression 
models.
. 
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Table 5 
 
Odds Ratio of Future Cancer Occurrence with Subjective Sleep Quality Parameters. Odds Ratios, Standard Errors and P-
Values for Bivariate Logistic Regression, Logistic Regression with Clustered Robust Standard Error Estimation and Firth 
Logit Regression with Penalized Maximum Likelihood Estimation   
 
 
Logistic Regression 
Logistic Regression with 
Clustered Robust SE Estimation 
Firth Logit Regression with 
Penalized MLE 
Sleep 
parameter 
OR [CI] SE 
p-
value 
OR [CI] SE 
p-
value 
OR [CI] SE 
p- 
value 
Global 
PSQI 
0.94 [0.87, 
1.01] 
0.037 0.115 
0.94 [0.87, 
1.02] 
0.038 0.124 
0.94 [0.87, 
1.02] 
0.039 0.128 
Sleep 
quality 
0.74 [0.52, 
1.06] 
0.137 0.106 
0.74 [0.51, 
1.07] 
0.139 0.112 
0.75 [0.52, 
1.07] 
0.184 0.118 
Sleep 
latency 
0.89 [0.68, 
1.18] 
0.126 0.419 
0.89 [0.66, 
1.21] 
0.138 0.458 
0.90 [0.68, 
1.18] 
0.140 0.446 
Sleep 
duration 
0.81 [0.58, 
1.12] 
0.136 0.203 
0.81 [0.54, 
1.19] 
0.161 0.282 
0.81 [0.58, 
1.13] 
0.168 0.218 
Sleep 
efficiency 
0.99 [0.81, 
1.22] 
0.104 0.944 
0.99 [0.81, 
1.22] 
0.103 0.943 
1.00 [0.82, 
1.23] 
0.104 0.995 
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Sleep 
disturbances 
0.81 [0.53, 
1.26] 
0.181 0.355 0.81 [0.55, 
1.21] 
0.166 0.314 0.82 [0.53, 
1.27] 
0.221 0.373 
Sleep 
medication 
use 
0.88 [0.69, 
1.13] 
0.111 0.324 
0.88 [0.69, 
1.13] 
0.111 0.326 
0.89 [0.70, 
1.14] 
0.124 0.367 
Daytime 
dysfunction 
0.75 [0.52, 
1.09] 
0.141 0.131 
0.75 [0.54, 
1.05] 
0.127 0.094 
0.76 [0.53, 
1.09] 
0.186 0.138 
Note. PSQI is Pittsburgh Sleep Quality Index. OR is odds ratio. CI is 95% confidence interval. SE is standard error.  MLE  
is maximum likelihood estimation.
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Similarly, a model of future cancer occurrence on global PSQI including all 
variables of interest yielded no significant results.  Please see Table 6.   Given the lack of 
significant findings between future cancer occurrence and global sleep quality, models of 
future cancer occurrence on PSQI subdomains that included all variables of interest were 
not pursued.  
Table 6 
Firth Logit Regression with Penalized MLE for Future Cancer Occurrence, Global 
PSQI, and Other Variables of Interest  
Variable  OR [CI] SE p-value 
Global PSQI 0.99 [0.91, 1.08] 0.043 0.586 
Age/race/gender interaction term  0.97 [0.46, 1.02] 0.240 0.227 
Gender  0.75 [0.45, 1.26] 0.261 0.281 
Age  1.03 [1.01, 1.06] 0.012 0.008 
Race  8.62 [0.34, 216.07] 1.640 0.190 
Education   1.15 [0.85, 156] 0.155 0.361 
Smoking status  1.39 [0.84, 2.28] 0.253 0.198 
Depressive symptoms 0.40 [0.13, 1.26] 0.584 0.117 
Alcohol use 0.85 [0.51, 1.43] 0.266 0.541 
Income  0.96 [0.87, 1.26] 0.094 0.633 
Physical activity 0.88 [0.47, 1.65] 0.322 0.683 
Time  1.08 [0.90, 1.30] 0.094 0.424 
Note. N=745; McFadden’s R2 = 0.05; 2(14df) = 21.6, p>0.05. PSQI is Pittsburgh Sleep 
Quality Index. OR is odds ratio. CI is 95% confidence interval. SE is standard error.  
MLE is maximum likelihood estimation. 
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Hypothesis 1.2 
The second hypothesis for Research Question 1 predicted that both short sleep 
duration and long sleep duration as compared to normal/healthy sleep duration would be 
associated with increased future cancer occurrence.  To explore a possible relationship 
between sleep duration parameters and future cancer occurrence, cancer status at time 
two was analyzed with continuous hours of sleep, categorical sleep duration based on 
NSF sleep recommendations, and data-derived categories of sleep duration.  Initially, 
bivariate logistic regressions were performed for cancer on each operationalization of 
sleep duration using logistic regression, logistic regression with a robust standard error 
estimator, and logistic regression using penalized maximum likelihood estimation (the 
Firth method).  Please see Table 7 for results.  Recall the Firth method was chosen due to 
the impact of the small number of cancer cases on the data.  
9
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Table 7 
Odds Ratio of Future Cancer Occurrence with Sleep Duration Parameters. Odds Ratios, Standard Errors and P-Values for 
Bivariate Logistic Regression, Logistic Regression with Clustered Robust Standard Error Estimation and Firth Logit 
Regression with Penalized Maximum Likelihood Estimation   
Logistic Regression Logistic Regression with 
Clustered Robust SE 
Estimation 
Firth Logit Regression with 
Penalized MLE 
Sleep parameter OR [CI] SE 
p-
value 
OR [CI] SE 
p-
value 
OR [CI] SE 
p-
value 
Continuous hours of 
sleep 
1.27 [1.02, 
1.57] 
0.141 0.035 
1.26 [0.98, 
1.63] 
0.165 0.071 
1.26 [1.02, 
1.57] 
0.111 0.036 
NSF Short sleep <7 
hours 
0.77 [0.46, 
1.3] 
0.205 0.336 
0.77 [0.46, 
1.30] 
0.204 0.335 
0.78 [0.47, 
1.31] 
0.263 0.344 
Short sleep <5.3 
hours 
2.34 [1.11, 
4.97] 
.898 0.026 
2.34 [1.10, 
4.99] 
0.903 0.026 
2.41 [1.16, 
5.04] 
0.375 0.019 
NSF Long sleep >8 
hours 
1.95 [0.98, 
3.87] 
0.681 0.055 
1.95 [0.98, 
3.88] 
0.685 0.057 
1.99 [1.01, 
3.90] 
0.344 0.046 
Long sleep >7.5 hours 
2.59 [1.55, 
4.31] 
0.673 0.000 
2.59 [1.55, 
4.33] 
0.678 0.000 
2.59 [1.56, 
4.30] 
0.258 0.000 
Note. OR is odds ratio. CI is 95% confidence interval. SE is standard error. MLE is maximum likelihood estimation. NSF is 
National Sleep Foundation. 
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In bivariate analysis, hours of sleep treated as a continuous variable was 
significant at a <0.05 p-value.  For each hour increase in sleep per day, the odds of having 
cancer occur in the future increase by 26%.  When sleep duration was categorized using 
NSF recommendations, short sleep duration (<7 hours per night) was not related to future 
cancer, but long sleep duration (>8 hours per night) was weakly related (p=0.046).  
Compared with a normal sleep duration of 7-8 hours per night, the odds of cancer 
occurring in the future with >8 hours of sleep per night are 1.99 times higher, however 
the 95% confidence interval for this result comes very close to including the number one 
(95% CI 1.01-3.90).  Finally, the sleep duration categories derived from the data proved 
to have a strong relationship with future cancer.  Compared with a normal sleep duration 
(5.3-7.5 hours per night), the odds of a future cancer occurrence are 2.41 times higher for 
those with less than 5.3 hours of sleep per night.  Compared with a normal sleep duration 
of 5.3-7.5 hours per night, the odds of a future cancer occurrence are 2.59 times higher 
for those with more than 7.5 hours of sleep per night.  
When all other variables of interest are added to the model, continuous hours of 
sleep no longer had a significant relationship with future cancer (see Table 8).  
Table 8 
Firth Logit Regression with Penalized MLE for Future Cancer Occurrence, Continuous 
Hours of Sleep, and Other Variables of Interest   
Variable OR [CI] SE p-value 
Continuous hours of sleep 1.20 [0.95, 1.52] 0.120 0.130
Age/race/gender interaction term 0.77 [0.93, 1.02] 0.024 0.272
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Gender  0.74 [0.45, 1.22] 0.255 0.240
Age  1.37 [1.01, 1.06] 0.012 0.008
Race  6.68 [0.29, 155.42] 1.606 0.237
Education   1.11 [0.83, 1.50] 0.151 0.481
Smoking status  1.44 [0.88, 2.35] 0.251 0.148
Depressive symptoms 0.53 [0.85, 1.43] 0.507 0.209
Alcohol use 0.87 [0.52, 1.47] 0.264 0.610
Income  1.04 [0.87, 1.25] 0.093 0.664
Physical activity 1.23 [0.44, 1.52] 0.319 0.520
Time  1.09 [0.91, 1.31] 0.093 0.333
Note. N=777; McFadden’s R2 = 0.054; 2(14df) = 23.6, p>0.05. OR is odds ratio. 
CI is 95% confidence interval. SE is standard error. MLE is maximum likelihood 
estimation. 
A model of sleep duration categorized according to NSF recommendations that 
included variables for individual differences and other cognitive-behavioral responses to 
stress, the relationship between the long sleep category (>8 hours per night) and future 
cancer improved in strength (p=0.024). In this model, the odds of future cancer 
occurrence increase 122% for those sleeping more than 8 hours a night compared to those 
sleeping 7-8 hours per night (see Table 9).  
Table 9 
Firth Logit Regression with Penalized MLE for Future Cancer Occurrence, NSF Sleep 
Duration Categories, and Other Variables of Interest    
Variable OR [CI] SE p-value 
NSF Short sleep (<7 hours) 0.93 [0.54, 1.58] 0.271 0.776 
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NSF Long sleep (>8 hours) 2.22 [1.11, 4.46] 0.355 0.024 
Age/race/gender interaction term 0.97 [0.93, 1.02] 0.024 0.255 
Gender  0.74 [0.45, 1.22] 0.256 0.234 
Age  1.03 [1.01, 1.06] 0.012 0.008 
Race  7.39 [0.32, 172.43] 1.607 0.213 
Education   1.12 [0.83-1.51] 0.151 0.451 
Smoking status  1.46 [0.89-2.40] 0.252 0.132 
Depressive symptoms 0.50 [0.18-1.34] 0.506 0.169 
Alcohol use 0.89 [0.53-1.49] 0.266 0.651 
Income  1.05 [0.87-1.26] 0.093 0.627 
Physical activity 0.81 [0.43-1.52] 0.320 0.518 
Time  1.10 [0.92-1.32] 0.094 0.309 
Note. N=777, McFadden R2 = 0.061; 2(14df) = 26.9, p<0.05. NSF is National 
Sleep Foundation. CI is 95% confidence interval. SE is standard error. MLE is  
maximum likelihood estimation. 
Finally, when all other variables of interest at added the model, the relationships 
between sleeping less than 5.3 hours per night and future cancer and sleeping more than 
7.5 hours per night and future cancer remained strong.  The odds of future cancer were 
4.5 times higher for those sleeping less than 5.3 hours per night compared with those 
sleeping 5.3-7.5 hours per night.  However, the confidence interval for this odds ratio is 
large (95% CI ranged 2.03 to 9.99).  The odds of future cancer were 2.88 times higher for 
those sleeping more than 7.5 hours per night compared with those sleeping 5.3 to 7.5 
hours per night (see Table 10). 
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Table 10 
Firth Logit Regression with Penalized MLE for Future Cancer Occurrence, Data-
Derived Sleep Duration Categories, and Other Variables of Interest   
Variable OR [CI] SE p-value 
Short sleep (<5.3 hours) 4.51 [2.03, 9.99] 0.406 0.000 
Long sleep (>7.5  hours) 2.88 [1.70, 4.90] 0.271 0.000 
Age/race/gender interaction term 0.97 [0.93, 1.02] 0.023 0.234 
Gender  0.66 [0.39, 1.09] 0.261 0.106 
Age  1.03 [1.01, 1.06] 0.012 0.006 
Race  6.57 [0.30, 142.82] 1.571 0.231 
Education   1.14 [0.84, 1.55] 0.156 0.410 
Smoking status  1.48 [0.90, 2.44] 0.255 0.125 
Depressive symptoms 0.40 [0.14, 1.12] 0.529 0.082 
Alcohol use 0.89 [0.52, 1.50] 0.268 0.652 
Income  1.08 [0.89, 1.30] 0.096 0.448 
Physical activity 0.79 [0.42, 1.49] 0.326 0.460 
Time  1.14 [0.95, 1.38] 0.095 0.157 
Note. N=777, McFadden R2 = 0.098;2(14df) = 43.3, p<0.05. OR is odds ratio.  
CI is 95 %confidence interval. SE is standard error. MLE is maximum likelihood 
estimation. 
Individual Differences and Other Cognitive-Behavioral Responses to Stress 
Contrary to expected based on the literature review, age was the only individual 
differences variable that was significantly related to future cancer in all models.  Other 
individual differences (gender, race, income, and education) and other cognitive-
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behavioral responses to stress (smoking, alcohol use, physical activity, and depressive 
symptoms) were not associated with future cancer occurrence.  
Research Question 2 Results 
Figure 3 
Model of Allostatic Load-Future Cancer Occurrence 
Allostatic Load and Future Cancer Occurrence 
Research Question 2 pertained to exploring a possible relationship between 
allostatic load and the seven physiologic domains and future cancer occurrence.  In order 
to be able to answer Research Question 2, values for allostatic load for each participant 
needed to be computed using confirmatory factor analysis for a previously validated 
bifactor model (Wiley et al., 2016).  Descriptive statistics for the sample for each 
allostatic load indicator are listed in Table 11.  Figure 2 shows a diagram of the CFA. 
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Table 11 
Descriptive Statistics for Allostatic Load Indicators 
Indicator Mean (SD) # of cases 
missing data 
Sympathetic nervous system 
    Urinary epinephrine (ng/mL) 1.32 (0.78) 5 
    Urinary norepinephrine (ng/mL) 17.85 (8.77) 0 
Parasympathetic nervous system 50 
    R-R interval standard deviation, ms 35.66 (17.30) 
    Root mean square of successive differences, ms 21.78 (16.96) 
    Low-frequency heart rate variability, ms2 441.76 (627.80) 
    High-frequency heart rate variability, ms2 282.89 (733.07) 
    Resting heart rate, beats/min 72.74 (10.64) 
Hypothalamic-pituitary-adrenal axis 
    Urinary cortisol (ug/dL) 0 
    Dehydroepiandrosterone (ug/dL) 111.86 (76.96) 1 
Inflammation 
    C-reactive protein (ug/mL) 2.45 (3.43) 4 
    Interleukin-6 (pg/mL) 2.49 (2.13) 0 
    Fibrinogen (mg/dL) 333.63 (79.01) 4 
    Soluble E-selectin (ng/mL) 40.94 (20.11) 0 
    Soluble intracellular adhesion molecule 1 (ng/mL) 279.79 (93.29) 0 
Cardiovascular 
    Pulse pressure (mmHg) 54.78 (14.09) 0 
    Systolic blood pressure (mmHg) 130.15 (17.38) 0 
Glucose  
    Fasting blood glucose (mg/dL) 100.52 (22.62) 0 
   Glycosylated hemoglobin, % 5.96 (0.91) 4 
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    Homeostasis model-assessed insulin resistance 3.21 (2.99) 0 
Lipids 
    Waist-to-hip circumference ratio 0.89 (0.91) 4 
    High-density lipoprotein cholesterol (mg/dL) 54.66 (17.16) 1 
    Low-density lipoprotein cholesterol 107.40 (34.39) 1 
   Triglycerides (mg/dL) 131.11 (82.22) 0 
 Note. N=769. SD is standard deviation. 
Figure 4 
 Diagram of the Confirmatory Factor Analysis for Allostatic Load 
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The factor loadings for each indicator on both its domain-specific factor and the 
overall allostatic load factor are reported in Table 12. All factor loadings are significant at 
a <0.05 p-value with the exception of the loadings for WHR and HDL onto the lipid 
factor.  
Table 12 
Standardized Factor Loadings for Bifactor CFA 
Domain Indicator Domain loadings 
[CI] 
p- 
value 
AL loadings 
[CI] 
p- 
value 
Sympathetic nervous system 
    Urinary epinephrine 0.620 [0.569, 
0.670] 
0.000 0.138 [0.009, 
0.266] 
0.036 
    Urinary norepinephrine 0.772 [0.713, 
0.832] 
0.000 0.347 [0.243, 
0.451] 
0.000 
Parasympathetic nervous 
system 
    R-R interval standard 
       deviation 
-0.993 [-1.006, 
-0.980] 
0.000 -0.115 [-0.228, 
-0.002] 
0.047 
    Root mean square of 
       successive 
      differences 
-0.825 [-0.854, 
-0.795] 
0.000 -0.125 [-0.231, 
-0.019] 
0.021 
    Low-frequency power -0.831 [-0.862, 
-0.800] 
0.000 -0.052 [-0.169, 
0.064] 
0.377 
    High-frequency power -0.768 [-0.804, 
-0.732] 
0.000 -0.142 [-0.242, 
-0.043] 
0.005 
    Resting heart rate 0.481 [0.422, 
0.541] 
0.000 0.033 [-0.089, 
0.155] 
0.598 
Hypothalamic-pituitary- 
 adrenal axis 
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  Urinary cortisol 0.372 [0.279, 
0.464] 
0.000 0.035 [-0.062, 
0.132] 
0.479 
    Dehydroepiandrosterone 0.450 [0.330, 
0.569] 
0.000 0.221 [0.126, 
0.315] 
0.000 
Inflammation 
    C-reactive protein 0.806 [0.730, 
0.881] 
0.000 0.225 [0.100, 
0.350] 
0.000 
    Interleukin-6 0.564 [0.488, 
0.639] 
0.000 0.252 [0.170, 
0.334] 
0.000 
    Fibrinogen 0.613 [0.542, 
0.684] 
0.000 0.062 [-0.036, 
0.159] 
0.218 
    Soluble E-selectin 0.169 [0.083, 
0.255] 
0.000 0.274 [0.188, 
0.361] 
0.000 
    Soluble intracellular 
        adhesion molecule 1 
0.214 [0.121, 
0.307] 
0.000 0.236 [0.140, 
0.333] 
0.000 
Cardiovascular 
    Pulse pressure 0.992 [0.966, 
1.019] 
0.000 0.100 [0.008, 
0.193] 
0.000 
    Systolic blood pressure 0.796 [0.767, 
0.824] 
0.000 0.254 [0.179, 
0.330] 
0.034 
Glucose 
    Fasting blood glucose 0.928 [0.890, 
0.966] 
0.000 0.372 [0.277, 
0.467] 
0.000 
   Glycosylated hemoglobin, 
   % 
0.640  [0.553, 
0.727] 
0.000 0.239 [0.128, 
0.323] 
0.000 
    Homeostasis model-   
        assessed-IR 
0.351  [0.265, 
0.437] 
0.000 0.621 [0.507, 
0.708] 
0.000 
Lipids 
    Waist-to-hip 
        circumference 
0.326 [-0.084, 
0.737] 
0.119 0.801 [0.666, 
0.936] 
0.000 
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    HDL cholesterol 0.173 [-0.088, 
0.433] 
0.194 -0.649 [-0.731, 
-0.568] 
0.000 
    LDL cholesterol -0.230 [-0.328, 
-0.131] 
0.000 0.128 [0.008, 
0.247] 
0.036 
   Triglycerides -0.429 [-0.734, 
-0.124] 
0.006 0.693 [0.523, 
0.836] 
0.000 
Note. CI is 95% confidence interval. AL is allostatic load. IR is insulin resistance. HDL is 
high density lipoprotein. LDL is low density lipoprotein.  
Goodness of fit test results for the CFA are reported in Table 13.  Overall, 
adequate model fit was achieved given a RMSEA of 0.064 and a CFI of 0.913.  
Table 13  
Goodness of Fit Testing of Bifactor CFA 
Fit test 
Chi square 776.454 189 degrees of freedom p-value 0.000 
RMSEA 0.064 90% CI 0.059-0.068 Probability RMSEA < 0.05= 0.000 
CFI 0.913 
TLI 0.883 
Note. RMSEA is root mean square error of approximation. CFI is comparative fit index.  
TLI is Tucker Lewis index.  
Standardized factor scores for allostatic load and for the 7 individual domains of 
allostatic load for each study participant were exported from MPlus into SPSS and Stata 
for analysis to answer research questions 2 through 4.  Table 14 reports descriptive 
statistics for the standardized allostatic load factor scores. 
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Table 14 
Descriptive Statistics for Standardized Factor Scores for Allostatic Load and for 7 
Physiologic Domains of Allostatic Load 
Variable Mean (SD) Range 
Allostatic load 0 (0.92) -2.213 to 2.696 
Sympathetic Nervous System 
Domain 
0 (0.30) -0.996 to 0.998 
Parasympathetic Nervous 
System Domain 
0 (0.43) -1.467 to 1.946 
Lipid Domain 
0 (0.02) -0.070 to 0.069 
Glucose Domain 
0 (0.16) -0.362 to 1.045 
HPA Axis Domain 
0 (0.22) -0.902 to 0.53 
Cardiovascular Domain 
0 (13.93) -29.024 to 52.107 
Inflammation Domain 
0 (0.79) -2.019 to 2.585 
Note. SD is standard deviation. 
Hypothesis 2.1 
It was hypothesized that increased allostatic load would be associated with 
increased future cancer occurrence.  Bivariate analysis results for cancer on allostatic 
load factor scores were performed using logistic regression, logistic regression with a 
robust standard error estimator, and logistic regression using penalized maximum 
likelihood estimation (the Firth method).  Please see Table 15.  
1
0
7
 
Table 15 
Odds Ratio of Future Cancer Occurrence with Allostatic Load. Odds Ratios, Standard Errors and P-Values for Bivariate 
Logistic Regression, Logistic Regression with Clustered Robust Standard Error Estimation and Firth Logit Regression with 
Penalized Maximum Likelihood Estimation   
Logistic Regression Logistic Regression with 
Clustered Robust SE Estimation 
Firth Logit Regression with 
Penalized MLE 
OR [CI] SE p-
value 
OR [CI] SE p-
value 
OR [CI] SE p-
value 
Allostatic load 0.98 [0.76, 
1.26] 
0.127 0.864 0.98 [0.76, 
1.26] 
0.127 0.864 0.98 [0.76, 
1.26] 
0.127 0.864 
Sympathetic 1.28 [0.58, 
2.85] 
0.522 0.539 1.28 [0.60, 
2.75] 
0.500 0.521 1.28 [0.58, 
2.83] 
0.406 0.547 
Parasympathetic 1.81 [1.05, 
3.13] 
0.504 0.032 1.81 [1.01, 
3.25] 
0.540 0.045 1.81 [1.05, 
3.12] 
0.277 0.033 
Lipid 287317 
[10.52, 
7.84x109] 
1497412 0.016 287317 [5.48, 
1.51x1010] 
1593008 0.023 268337 [10.2, 
7.1x109] 
5.19 0.016 
Glucose 1.50 [0.38, 
6.01] 
1.062 0.564 1.50 [0.38, 
6.05] 
1.068 0.567 1.62 [0.42, 
6.32] 
0.694 0.486 
HPA 0.85 [0.29, 
2.46] 
0.461 0.761 0.85 [0.29, 
2.46] 
0.471 0.766 0.84 [0.29, 
2.42] 
0.542 0.744 
Cardiovascular 0.99 [0.98, 
1.01] 
0.009 0.388 0.99 [0.97, 
1.01] 
0.009 0.411 0.99 [0.98, 
1.01] 
0.009 0.409 
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Inflammation 0.89 [0.66, 
1.21] 
0.137 0.463 0.89 [0.65, 
1.22] 
0.141 0.478 0.90 [0.66, 
1.21] 
0.153 0.474 
Note. OR is odds ratio. CI is 95% confidence interval. SE is standard error. MLE is maximum likelihood estimation.  HPA is 
hypothalamic-pituitary-adrenal  axis.
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As noted in Chapter III, the Firth method was chosen due to the impact of the 
small number of cancer cases on the data.  
Bivariate analysis for future cancer occurrence on allostatic load showed overall 
allostatic load did not have a relationship with future cancer occurrence.  To investigate 
the correlation identified between male gender and allostatic load, the sample was 
stratified by gender and analysis repeated.  No relationship was found between future 
cancer occurrence and allostatic load and male gender or female gender (results not 
shown).  
Consistent with the bivariate analysis, a model of future cancer occurrence on 
allostatic load including all variables of interest yielded no significant results.  Please see 
Table 16.  
Table 16 
Firth Logit Regression with Penalized MLE for Future Cancer Occurrence, Allostatic 
Load, and Other Variables of Interest  
Variable OR [CI] SE p-value 
Allostatic load 0.81 [0.58, 1.14] 0.172 0.233 
Age/race/gender interaction term 0.97 [0.93, 1.02] 0.023 0.239 
Gender  0.61 [0.33, 1.14] 0.317 0.124 
Age  1.03 [1.01, 1.06] 0.012 0.005 
Race  6.01 [0.27, 133.26] 1.581 0.257 
Education   1.10 [0.82, 1.49] 0.152 0.513 
Smoking status  1.45 [0.89, 2.38] 0.251 0.139 
Depressive symptoms 0.48 [0.18, 1.30] 0.506 0.150 
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Alcohol use 0.87 [0.52, 1.46] 0.265 0.589 
Income  1.04 [0.87, 1.25] 0.093 0.675 
Physical activity 0.88 [0.47, 1.67] 0.325 0.704 
Time  1.10 [0.92, 1.33] 0.094 0.288 
Note. N=747; McFadden’s R2 = 0.053; 2(14df) = 23.1, p>0.05. OR is odds ratio. CI is 
95% confidence interval. SE is standard error. MLE is maximum likelihood estimation.) 
 
 
Hypothesis 2.2 
It was predicted that the inflammation domain, sympathetic nervous system 
domain, and hypothalamic-pituitary-adrenal axis domain would be associated with the 
occurrence of future cancers.  Bivariate logistic regression results of future cancer 
occurrence on the seven physiologic domain factor scores are all non-significant except 
in the case of the parasympathetic domain factor and the lipid domain factor.  None of the 
hypothesized domains proved to be related to future cancer.  As the other physiologic 
domains did not demonstrate a relationship with future cancer occurrence, exploration of 
a full model containing all variables of interest was pursued only for the parasympathetic 
nervous system domain and the lipid domain.  In the full model, the relationships 
between parasympathetic nervous system domain score and future cancer and between 
lipid domain score and future cancer were no longer significant.  Please see Table 17 for 
parasympathetic nervous system domain full model results and Table 18 for lipid domain 
full model results. 
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Table 17  
 
Firth Logit Regression with Penalized MLE for Future Cancer Occurrence, 
Parasympathetic Nervous System Domain, and Other Variables of Interest  
 
Variable  OR [CI] SE p-value 
Parasympathetic nervous system 1.66 [0.94, 2.94] 0.292 0.082 
Age/race/gender interaction term  0.98 [0.93, 1.02] 0.024 0.294 
Gender  0.70 [0.42, 1.18] 0.261 0.180 
Age  1.03 [1.00, 1.05] 0.013 0.022 
Race  5.72 [0.24, 136.26] 1.617 0.281 
Education   1.12 [0.83, 1.15] 0.151 0.446 
Smoking status  1.44 [0.88, 2.35] 0.252 0.151 
Depressive symptoms 0.47 [0.17, 1.27] 0.506 0.137 
Alcohol use 0.90 [0.53, 1.51] 0.265 0.679 
Income  1.04 [0.87, 1.25] 0.094 0.658 
Physical activity 0.82 [0.44, 1.53] 0.320 0.528 
Time  1.09 [0.91, 1.31] 0.093 0.339 
Note. N=747, McFadden R2 = 0.057; 2(14df) = 24.8, p<0.05. OR is odds ratio. CI  
is 95% confidence interval. SE is standard error. MLE is maximum likelihood 
estimation.) 
 
 
Table 18 
 
Firth Logit Regression with Penalized MLE for Future Cancer Occurrence, Lipid 
Domain, and Other Variables of Interest   
 
Variable  OR [CI] SE p-value 
Lipid domain  
1479.51 [0.01, 
17.6x107] 
5.962 0.221 
Age/race/gender interaction term  0.97 [0.93, 1.02] 0.024 0.276 
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Gender  0.89 [0.51, 1.55] 0.282 0.678 
Age  1.03 [1.01, 1.06] 0.012 0.008 
Race  6.01 [0.26, 139.02] 1.602 0.263 
Education   1.12 [0.83, 1.50] 0.151 0.468 
Smoking status  1.40 [0.85, 2.30] 0.253 0.183 
Depressive symptoms 0.49 [0.18, 1.33] 0.508 0.161 
Alcohol use 0.88 [0.52, 1.48] 0.265 0.627 
Income  1.05 [0.87, 1.26] 0.094 0.609 
Physical activity 0.84 [0.45, 1.58] 0.320 0.595 
Time  1.12 [0.93, 1.34] 0.094 0.241 
Note. N = 747, McFadden R2 = 0.053; 2(14df) = 23.2, p>0.05. OR is odds ratio. CI is 
95% confidence interval. SE is standard error. MLE is maximum likelihood estimation. 
 
 
Individual Differences and Other Cognitive-Behavioral Responses to Stress 
Consistent with results from analysis for Research Question 1, age is the only 
individual differences variable associated with future cancer occurrence.  Other 
individual differences (gender, race, income, and education) and other cognitive-
behavioral responses to stress (smoking, alcohol use, physical activity, and depressive 
symptoms) were not associated with future cancer occurrence.   
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Research Question 3 Results 
 
Figure 5 
 
Model of Sleep-Allostatic Load 
 
 
 
 
Sleep and Allostatic Load  
Research Question 3 investigated the relationship between subjective sleep 
quality, sleep duration and allostatic load and the seven physiologic domains.  It was 
hypothesized that poor self-reported, subjective sleep quality would be associated with 
increased allostatic load.  To answer this research question, a relationship between the 
subjective sleep quality parameters measured by the PSQI was investigated.  Only full 
model linear regressions including all variables of interest were conducted.  Results show 
poor global sleep quality was associated with increased allostatic load as hypothesized. 
Please see Table 19.  
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Table 19  
Linear Regression Results for Allostatic Load, Global PSQI Sleep Quality, and Other 
Variables of Interest  
Variable  Coefficient [CI] SE p-value 
Global sleep quality  0.14 [0.03, 0.29] 0.009 0.014 
Age/race/gender interaction term  0.00 [-0.01, 0.01] 0.004 0.964 
Gender  -1.12 [-1.23, -1.01] 0.060 0.000 
Age  0.00 [-0.01, 0.00] 0.003 0.832 
Race  -0.09 [-0.76, 0.57] 0.341 0.780 
Education   -0.10 [-0.17, -0.03] 0.036 0.006 
Smoking status  0.02 [-0.10, 0.13] 0.060 0.752 
Depressive symptoms 0.09 [-0.09, 0.28] 0.096 0.330 
Alcohol use -0.11 [-0.23, 0.01] 0.061 0.081 
Income  -0.03 [-0.07, 0.01] 0.020 0.087 
Physical activity 0.30 [0.17, 0.43] 0.064 0.000 
Time  0.01 [-0.03, 0.05] 0.021 0.614 
Note. N=747; R2 = 0.38. PSQI is Pittsburgh Sleep Quality Index. CI is 95%  
confidence interval. SE is standard error.   
 
Hypothesis 3.2 
It was hypothesized that short sleep duration and long sleep duration as compared 
to normal/healthy sleep duration would be associated with increased allostatic load.  Data 
were analyzed for relationships between the sleep duration variables and allostatic load.  
No relationship was identified between overall allostatic load and any measure for sleep 
duration.  Please see Tables 20, 21, and 22.  
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Table 20  
 
Linear Regression Results for Allostatic Load, Continuous Hours of Sleep, and Other 
Variables of Interest  
 
Variable  Coefficient [CI] SE p-value 
Continuous hours of sleep  -0.023 [-0.073, 0.026] 0.025 0.357 
Age/race/gender interaction term  -0.001 [-0.008, 0.006] 0.003 0.791 
Gender  -1.098 [-1.209, -0.987] 0.057 0.000 
Age  -0.001 [-0.006, -0.005] 0.003 0.793 
Race  -0.138 [-0.714, 0.437] 0.293 0.637 
Education   -0.100 [-1.650, -0.035] 0.033 0.003 
Smoking status  0.011 [-0.098, 0.121] 0.056 0.840 
Depressive symptoms 0.129 [-0.400, 0.297] 0.086 0.135 
Alcohol use -0.109 [-0.224, 0.006] 0.590 0.064 
Income  -0.360 [-0.076, 0.003] 0.020 0.071 
Physical activity 0.311 [0.177, 0.444] 0.068 0.000 
Time  0.010 [-0.029, 0.050] 0.020 0.608 
Note. N=744; R2= 0.378. CI is 95% confidence interval. SE is standard error.  
 
 
Table 21  
 
Linear Regression Results for Allostatic Load, NSF Sleep Duration Categories, and 
Other Variables of Interest  
 
Variable  Coefficient [CI] SE p-value 
Short sleep duration (<7 hours) 0.074 [-0.038, 0.187] 0.057 0.195 
Long sleep duration (>8 hours) 0.125 [-0.650, 0.316] 0.097 0.198 
Age/race/gender interaction term  -0.001 [-0.007, 0.006] 0.003 0.863 
Gender  -1.101 [-1.212, -0.990] 0.056 0.000 
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Age  -0.001 [-0.006, 0.005] 0.003 0.794 
Race  -0.159 [-0.733, 0.416] 0.293 0.588 
Education   -0.099 [-0.164, -0.034] 0.033 0.003 
Smoking status  0.009 [-0.100, 0.119] 0.056 0.871 
Depressive symptoms 0.135 [-0.032, 0.303] 0.085 0.112 
Alcohol use -0.109 [-0.224, 0.006] 0.059 0.064 
Income  -0.035 [-0.074, 0.005] 0.020 0.085 
Physical activity 0.311 [0.178, 0.444] 0.068 0.000 
Time  0.011 [-0.029, 0.051] 0.020 0.586 
Note. N=744. NSF is National Sleep Foundation. CI is 95% confidence interval. SE is 
standard error.  
 
 
Table 22 
 
Linear Regression Results for Allostatic Load, Data-Derived Sleep Duration Categories, 
and Other Variables of Interest  
 
Variable  Coefficient [CI] SE p-value 
Short sleep duration (<7 hours) 0.128 [-0.072, 0.328] 0.102 0.209 
Long sleep duration (>8 hours) 0.010 [-0.118, 0.138] 0.065 0.879 
Age/race/gender interaction term  -0.001 [-0.008, 0.006] 0.003 0.770 
Gender  -1.103 [-1.215, -0.992] 0.057 0.000 
Age  -0.001 [-0.006, 0.005] 0.003 0.799 
Race  -0.133 [-0.710, 0.445] 0.294 0.652 
Education   -0.010 [-0.165, -0.035] 0.033 0.003 
Smoking status  0.009 [-0.100, 0.119] 0.056 0.866 
Depressive symptoms 0.125 [-0.044, 0.294] 0.086 0.149 
Alcohol use -0.107 [-0.223, 0.008] 0.059 0.068 
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Income  -0.035 [-0.075, 0.004] 0.020 0.082 
Physical activity 0.312 [0.179, 0.445] 0.068 0.000 
Time  0.012 [-0.028, 0.052] 0.020 0.556 
Note. N=744. R2=0.379. CI is 95% confidence interval. SE is standard error.  
 
 Female gender, increasing education level, and being physically active were all 
associated with lower allostatic load scores.  Other individual differences and other 
cognitive-behavioral responses to stress were not found to have a relationship with 
allostatic load in the models of subjective sleep quality and allostatic load and models of 
sleep duration and allostatic load.   
Hypothesis 3.3 
It was hypothesized that poor sleep would be associated with the inflammation 
domain, glucose domain, lipid domain, and cardiovascular domain.  Given that overall 
allostatic load was significantly related to global PSQI, relationships between the seven 
physiologic domain factors and subjective sleep quality were explored.  The sympathetic 
nervous system domain, parasympathetic nervous system domain, glucose domain, lipid 
domain, inflammation domain, and cardiovascular domain were not associated with 
subjective sleep quality, contrary to what was anticipated.  Only the HPA axis domain 
proved to be associated with subjective sleep quality.  Subjects with poor global sleep 
quality had lower HPA factor scores (see Table 23).  Recall that increasing scores for the 
HPA axis domain are indicative of worse physiologic dysfunction in the HPA axis 
domain. These results show the opposite finding from what was expected: poor sleep 
quality was associated with decreased, or better, HPA axis domain factor scores.   
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Table 23  
 
Linear Regression Results for HPA Axis Domain, Global PSQI Sleep Quality, and Other 
Variables of Interest  
 
Variable  Coefficient [CI] SE p-value 
Global sleep quality  -0.04 [-0.07, -0.02] 0.014 0.002 
Age/race/gender interaction term  0.00 [0.00, 0.00] 0.001 0.287 
Gender  -0.17 [-0.20, -0.14] 0.014 0.000 
Age  -0.01 [-0.01, -0.01] 0.001 0.000 
Race  -0.06 [-0.20, 0.07] 0.071 0.354 
Education   0.01 [0.00, 0.03] 0.008 0.086 
Smoking status  0.01 [-0.02, 0.03] 0.014 0.666 
Depressive symptoms -0.02 [-0.07, 0.02] 0.023 0.359 
Alcohol use 0.02 [-0.01, 0.05] 0.015 0.185 
Income  -0.01 [-0.02, 0.00] 0.005 0.102 
Physical activity -0.02 [-0.05, 0.01] 0.015 0.166 
Time  -0.01 [-0.02, 0.00] 0.005 0.260 
Note. N=747. R2 = 0.362. HPA is hypothalamic-pituitary-adrenal axis. PSQI is Pittsburgh 
Sleep Quality Index. CI is 95% confidence interval. SE is standard error.  
 
 
Female gender and older age were associated with lower HPA axis domain 
scores.  Other individual differences (race, education, and income) and other cognitive-
behavioral responses to stress (smoking status, alcohol use, depressive symptoms, and 
physical activity) were not associated with HPA axis domain scores.   
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Research Question 4 Results 
 
Figure 6  
 
Mediation Model 
 
 
 
Allostatic Load as Mediator for Sleep-Future Cancer Occurrence 
Research Question 4 pertained to investigating a potential mediating role for 
allostatic load in the sleep – future cancer occurrence relationship. The first step in 
answering this research question was to analyze future cancer occurrence, allostatic load, 
and sleep together.  Results for models with future cancer occurrence, allostatic load, and 
each of the three sleep duration variables and sleep quality including all variables of 
interest are found in Tables 24-27.  Analyzing all three main concepts together did not 
change results with one exception.  Adding allostatic load to the model of future cancer 
occurrence and sleep duration categories derived from the data results in gender having a 
significant relationship with future cancer occurrence, with females having a 49% lower 
odds of cancer.  Please see Table 24.  
 
 
 
 120 
Table 24  
 
Firth Logit Regression with Penalized MLE for Future Cancer Occurrence, Allostatic 
Load, Global PSQI Sleep Quality, and Other Variables of Interest  
 
Variable  OR [CI] SE p-value 
Allostatic load  0.79 [0.56, 1.12] 0.18 0.186 
Short sleep duration (<5.3 hours) 4.74 [2.12, 10.63] 0.41 0.000 
Long sleep duration (>7.5 hours) 2.97 [1.74, 5.07] 0.27 0.000 
Age/race/gender interaction term  0.97 [0.93, 1.02] 0.02 0.254 
Gender  0.51 [0.27, 0.96] 0.33 0.037 
Age  1.03 [1.01, 1.06] 0.01 0.006 
Race  5.80 [0.26, 128.29] 1.58 0.266 
Education   1.10 [0.81, 1.49] 0.16 0.554 
Smoking status  1.46 [0.88, 2.42] 0.26 0.138 
Depressive symptoms 0.40 [0.14, 1.13] 0.53 0.082 
Alcohol use 0.86 [0.51, 1.47] 0.27 0.588 
Income  1.08 [0.90, 1.31] 0.10 0.407 
Physical activity 0.87 [0.45, 1.67] 0.33 0.671 
Time  1.16 [0.96, 1.40] 0.10 0.126 
Note. N=747. McFadden’s R2 = 0.054; 2(14df) = 23.2, p>0.05. MLE is maximum 
likelihood estimation. OR is odds ratio. CI is 95% confidence interval. SE is standard 
error.  
 
 
Table 25 
 
Firth Logit Regression with Penalized MLE for Future Cancer Occurrence, Allostatic 
Load, Continuous Hours of Sleep, and Other Variables of Interest  
 
Variable OR [CI] SE p-value 
Allostatic load  0.82 [0.58, 1.14] 0.17 0.239 
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Global PSQI sleep quality 0.98 [0.59, 1.62] 0.26 0.932 
Age/race/gender interaction term  0.97 [0.93, 1.02] 0.02 0.268 
Gender  0.62 [0.33, 1.16] 0.32 0.132 
Age  1.03 [1.01, 1.06] 0.01 0.005 
Race  6.02 [0.27, 133.21] 1.58 0.256 
Education   1.10 [0.82, 1.49] 0.15 0.514 
Smoking status  1.45 [0.89, 2.37] 0.25 0.140 
Depressive symptoms 0.49 [0.18, 1.34] 0.52 0.163 
Alcohol use 0.87 [0.52, 1.46] 0.26 0.590 
Income  1.04 [0.87, 1.25] 0.09 0.675 
Physical activity 0.88 [0.47, 1.67] 0.32 0.706 
Time  1.10 [0.92, 1.33] 0.09 0.290 
Note. N=744. McFadden’s R2 = 0.058; 2(14df) = 25.1, p<0.05. MLE is maximum 
likelihood estimation. PSQI is Pittsburgh Sleep Quality Index. OR is odds ratio. CI is 
95% confidence interval. SE is standard error. 
 
 
Table 26 
 
Firth Logit Regression with Penalized MLE for Future Cancer Occurrence, Allostatic 
Load, NSF Sleep Duration Categories, and Other Variables of Interest 
 
Variable OR [CI] SE P-value 
Allostatic load  0.80 [0.57, 1.12] 0.17 0.201 
Short sleep duration (<7 hours) 0.96 [0.56, 1.63] 0.36 0.870 
Long sleep duration (>8 hours) 2.35 [1.17, 4.75] 0.02 0.017 
Age/race/gender interaction term  0.97 [0.93, 1.02] 0.32 0.285 
Gender  0.59 [0.31, 1.09] 0.01 0.093 
Age  1.03 [1.01, 1.06] 1.63 0.007 
Race  6.28 [0.26, 152.38] 0.15 0.259 
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Education   1.10 [0.81, 1.48] 0.25 0.545 
Smoking status  1.45 [0.88, 2.39] 0.37 0.141 
Depressive symptoms 0.68 [0.19, 1.37] 0.51 0.181 
Alcohol use 0.86 [0.51, 1.45] 0.27 0.573 
Income  1.05 [0.87, 1.26] 0.09 0.606 
Physical activity 0.89 [0.47, 1.68] 0.33 0.714 
Time  1.11 [0.92, 1.34] 0.10 0.260 
Note. N=744. McFadden’s R2 = 0.067; 2(14df) = 28.9, p<0.05. MLE is maximum 
likelihood estimation. NSF is National Sleep Foundation. OR is odds ratio. CI is  
95% confidence interval. SE is standard error.  
 
 
Table 27  
 
Firth Logit Regression with Penalized MLE for Future Cancer Occurrence, Allostatic 
Load, Data-Derived Sleep Duration Categories, and Other Variables of Interest 
 
Variable OR [CI] SE p-value 
Allostatic load  0.82 [0.59, 1.15] 0.172 0.249 
Continuous hours of sleep 1.20 [0.94, 0.52] 0.121 0.138 
Age/race/gender interaction term  0.98 [0.93, 1.02] 0.024 0.302 
Gender  0.61 [0.33, 1.13] 0.316 0.117 
Age  1.03 [1.01, 1.06] 0.012 0.007 
Race  5.77 [0.24, 138.19] 1.62 0.279 
Education   1.09 [0.81, 1.47] 0.152 0.558 
Smoking status  1.43 [0.87, 2.35] 0.252 0.153 
Depressive symptoms 0.53 [0.20, 1.45] 0.508 0.218 
Alcohol use 0.85 [0.51, 1.44] 0.265 0.552 
Income  1.04 [0.87, 1.25] 0.09 0.665 
Physical activity 0.87 [0.46, 1.65] 0.325 0.677 
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Time  1.10 [0.92, 1.33] 0.094 0.291 
Note. N=744. McFadden’s R2 = 0.106; 2(14df) = 45.7, p<0.05. MLE is maximum 
likelihood estimation. OR is odds ratio. CI is 95% confidence interval. SE is standard 
error.  
 
 
Proceeding further with the analysis for Research Question 4 hinged on positive 
findings from Research Questions 1, 2, and 3.  If no relationships were identified between 
sleep and future cancer, allostatic load and future cancer, or between sleep and allostatic 
load, then checking for mediation amongst these relationships is not possible.  Although 
sleep duration was found to be related to future cancer in Research Question 1, subjective 
sleep quality was not related to future cancer.  For Research Question 2, no relationship 
between allostatic load and future cancer was identified.  In the bivariate logistic 
regression model, parasympathetic nervous system domain score and future cancer were 
related, but this relationship became non-significant in the full model.  However, the 
parasympathetic nervous system domain was trending toward a relationship with cancer 
(p = 0.082).  Lastly, for Research Question 3, overall allostatic load was found to be 
related to subjective sleep quality but not sleep duration.  Given the lack of significant 
results for a relationship between the allostatic load and future cancer occurrence, and 
given that sleep duration was related to future cancer occurrence while subjective sleep 
quality was related to allostatic load, mediation analysis was not warranted.   
Summary 
With consideration given to individual differences (age, race, gender, education, 
and income) and other cognitive-behavioral differences (smoking, alcohol use in the last 
30 days, physical activity, and depression), relationships between sleep, allostatic load, 
 
 124 
and future cancer occurrence were explored.  Of the permutations of sleep duration, 
categorical sleep derived from the data fit the best.  Age was the only other measure to 
show a relationship with future cancer. Poor subjective sleep quality was associated with 
increased allostatic load.  Female gender, increasing education level, and being physically 
active were all associated with lower allostatic load scores.  Poor subjective sleep quality 
was associated with decreased hypothalamic-pituitary-adrenal axis domain scores.  No 
relationship was found between subjective sleep quality or the seven sleep domains and 
future cancer occurrence.  No relationship was found between allostatic load or the seven 
physiologic domains and future cancer occurrence.  No relationship was found between 
sleep duration and allostatic load.  Finally, allostatic load did not play a mediating role in 
the sleep – future cancer occurrence relationship. 
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CHAPTER V 
DISCUSSION 
 The purpose of this study was to examine secondary data from US adults for 
potential relationships between sleep, allostatic load, and future cancer occurrence.  The 
research questions were designed based on a conceptual framework of responses to 
stress.  The model depicts sleep, a cognitive-behavioral response to stress, as influencing 
allostatic load, a physiologic response to stress, and cancer, a disease.  Additionally, the 
model depicts allostatic load influencing cancer.  Sleep was operationalized as subjective 
sleep quality and sleep duration and measured at time one.  Information from the 
Pittsburgh Sleep Quality Index questionnaire was the source of all sleep variables.  A 
priori cut points for categorical sleep duration based on National Sleep Foundation 
recommendations were used for analysis; data were also explored for pertinent sleep 
duration categories in relation to the future cancer occurrence outcome variable. 
Allostatic load was operationalized using a validated bifactor model and measured at time 
one.  Cancer status was assessed at time two by self-report and was operationalized to 
include any cancer that occurred since time two.  Results confirm aspects of the 
relationships predicted by the conceptual framework.  Findings demonstrate a 
relationship between future cancer occurrence and categorical sleep duration, but no 
relationship between subjective sleep quality and future cancer occurrence.  Allostatic 
load is not associated with future cancer occurrence.  Subjective sleep quality is
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associated with allostatic load but sleep duration is not.  Finally, no interplay between all 
three main concepts was identified.    
Sleep and Future Cancer Occurrence 
Subjective Sleep Quality and Future Cancer Occurrence 
This study sought to investigate a potential relationship between subjective sleep 
quality and future cancer occurrence.  However, models of future cancer on self-reported, 
subjective sleep quality as measured by the Pittsburgh Sleep Quality Index (PSQI) did 
not show any relationship between sleep quality and future cancer.  Very few studies of 
subjective sleep quality in relation to future cancer were identified for comparison 
purposes and none utilized the PSQI to measure sleep quality.   One study found an 
increased risk of breast cancer in women with all three sleep quality complaints of 
nonrestorative sleep, difficulty initiating sleep,  and difficulty maintaining sleep (Sen et 
al., 2017).  Self-reported difficulty initiating and difficulty maintaining sleep were 
associated with an increased risk of prostate cancer (Sigurdardottir et al., 2013).  An 
increased risk for multiple cancer types was found among those with a diagnosis of 
insomnia at least 2 years prior to cancer diagnosis (Fang et al., 2015).  None of the 
comparison studies’ samples included US adults, the population studied in the current 
sample.  All the comparison studies used similar parameters of sleep quality to each that 
are different than those used by the present study.  These studies used a diagnosis of 
insomnia or criteria for the diagnosis of insomnia to measure sleep quality.  The present 
study utilizes self-reported sleep quality as measured by the PSQI which includes the
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domains of sleep quality, sleep latency, sleep duration, sleep efficiency, sleep 
disturbances, sleep medication use, and daytime dysfunction (Buysse et al., 1989).   
Sleep Duration and Future Cancer Occurrence 
Most of the studies of sleep and future cancer to date have examined sleep 
duration as the sleep parameter of interest, however operationalization of sleep duration 
varied widely.  This study examined sleep duration in several ways to determine what the 
best measure of sleep duration in relation to future cancer might be.  Sleep duration 
variables examined in this study included continuous hours of sleep per night, sleep 
duration categories based on sleep duration recommendations from the National Sleep 
Foundation (NSF), and sleep duration categories generated from the data based on the 
future cancer occurrence outcome.  After controlling for individual differences (age, race, 
gender, income, and education) and other cognitive behavioral responses to stress 
(smoking, alcohol use, physical activity, and depressive symptoms), future cancer had no 
relationship with continuous hours of sleep, a weak relationship with sleep duration 
categories based on NSF recommendations, and a strong relationship with sleep duration 
categories derived from the future cancer occurrence variable.  Recall normal sleep per 
NSF recommendations was 7 to 8 hours per while and normal sleep duration category 
derived from the data was 5.3 to 7.5 hours per night.     
 A review of the literature identified some evidence that concurs and some that 
disagrees with these findings.   A few studies that categorized short sleep duration 
similarly to the present study (between <5-6 hours per night) found short sleep duration 
to be associated with an increased risk of cancer.  A large prospective European study 
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found an increased risk of cancer (defined as any type of cancer) associated with <6 
hours of sleep at night baseline (von Ruesten, Weikert, Fietze, & Boeing, 2012).  Two 
studies of women and colon cancer found conflicting results.   One (Jiao et al., 2013) 
found the risk for colon cancer increased for those sleeping =/<5 hours; in contrast, the 
other did not identify an increased risk of colon cancer for those sleeping <5 hours per 
day (Devore et al., 2017).  Results from the Women’s Health Initiative Study found no 
increased risk of liver cancer for short sleep duration of <5 hours (Royse et al., 2017).  Of 
the 4 comparison studies identified here, 3 are of US women for specific cancer types.  
The remaining study of European men and women included all cancer except non-
melanoma skin cancer as the outcome.  In contrast, the present study is of middle-aged 
US adults and likely includes non-melanoma skin cancer in the future cancer occurrence 
outcome.   
Less evidence was found that concurred with the finding of an increased odds of 
future cancer occurrence with long sleep duration (defined as >7.5 hours per night).  
Three studies operationalized long sleep duration similarly to the present study (between 
7-8 hours per night).  These comparison studies of cancer (of any kind), colon cancer, and 
lung cancer did not find an increased cancer risk with long sleep duration (Devore et al., 
2017; Luojus et al., 2014; von Ruesten et al., 2012).  Of these three comparison studies, 
two are from Europe, one is of men only, and one is of women only.  Finally, one study 
of women that defined long sleep duration as 9 or more hours of sleep per night, different 
from the present study, showed an increased risk of liver cancer (Royse et al., 2017).   
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Allostatic Load and Future Cancer Occurrence 
 A relationship between allostatic load and future cancer had not been examined 
yet per the literature reviewed for the development of this study, and only a single article 
was identified that reported on an investigation of individual biomarkers as predictors of 
future cancer.  Results of that study showed higher blood glucose values were associated 
with an increased risk of future breast cancer (Agnoli et al., 2015).  Given the lack of 
evidence for or against an allostatic load- future cancer relationship, this study sought to 
determine if allostatic load was associated with future cancer occurrence.  Although it 
was hypothesized that overall allostatic load would be associated with future cancer, 
analysis of the data did not support this.   
Physiologic Domains of Allostatic Load and Future Cancer Occurrence 
Despite the lack of relationship between allostatic load and future cancer, the 7 
physiologic system factor scores were examined as predictors of future cancer.  This 
analysis was pursued in the hopes of identifying systems or indicators that might be 
related to future cancer for inclusion in subsequent studies of allostatic load and cancer.  
In bivariate logistic regressions, the parasympathetic system domain factor and the lipid 
domain factor each showed a relationship with future cancer, while the sympathetic 
system, HPA axis, inflammation system, glucose system, and cardiovascular system 
domains were not related to future cancer.  Higher, meaning worse, parasympathetic 
system domain scores were associated with increased future cancer.  This relationship 
disappeared in the full model in which age is a significant predictor of future cancer, 
indicating that parasympathetic system function worsens with increasing age.  However, 
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the relationship was trending toward significant (p-value = 0.08).  A review of the 
literature did not identify any studies examining parasympathetic system indicators as a 
predictor of future cancer occurrence.  However, one study was identified that 
demonstrated reduced heart rate variability (a component of the parasympathetic system 
domain) in cancer patients was associated with decreased survival (Guo et al., 2015).   
The lipid factor was significantly related to future cancer in the bivariate logistic 
regression, but as with the parasympathetic system, this relationship was eliminated in the 
full model.  However, the lipid factor produced unexpected results in relation to future 
cancer occurrence and needs further discussion.  In the bivariate logistic regression, the 
odds of future cancer are 268,337 times higher for each standard deviation increase in 
lipid factor score with a 95% confidence interval of 10 to over 7 million. There are a 
number of possible explanations for this unusual result.  First, the scale of the lipid factor 
differs from the other physiologic factors: for example, the standard deviation for overall 
allostatic load is close to 1, while the standard deviation of the lipid factor is 0.02.  
Another avenue that needs exploration is the derivation of the lipid factor.  In the 
established CFA utilized by this study, the lipid factor contains 5 indicators: waist-to-hip 
ratio, HDL, LDL, triglycerides and HOMA-IR (Wiley et al., 2016).  In the present study, 
LDL, triglycerides, and HOMA-IR load significantly both onto the lipid factor and onto 
the overall allostatic load factor.  Waist-to-hip ratio and HDL, however, load significantly 
onto overall allostatic load but not onto the lipid factor (please refer to Table 10 in 
Chapter IV for details).  It is possible the factor structure for the lipid factor does not fit 
as well for this study’s sample as it did in the original CFA study upon which this study is 
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based.  For example, the original CFA was produced with a larger sample size that 
included participants with cancer, and it is possible something about the physiologic 
function of the indicators for the lipid factor differs significantly for people with and 
without existing cancer.  
Sleep and Allostatic Load 
Subjective Sleep Quality and Allostatic Load 
Like the exploration of allostatic load on future cancer, there was little solid 
evidence on which to base suspicions of a relationship between allostatic load and 
subjective sleep quality. Despite the limited evidence, conceptually it is reasonable to 
hypothesize that poor subjective sleep quality is related to higher allostatic load, and the 
results of the analysis support this supposition.  Analysis of the data determined a 
relationship between allostatic load and subjective sleep quality was present.  Overall 
allostatic load was increased by poor global sleep quality, meaning poor sleep quality was 
associated with worse physiologic dysfunction. Two studies were identified for 
comparison. One study was identified that analyzed sleep quality using the PSQI and 
allostatic load directly.  Poor sleep quality was associated with higher allostatic load, but 
this relationship became non-significant after adjusting for self-reported health status 
(Judith E. Carroll et al., 2015).  The present study did not take health status into 
consideration.  Additionally, while Carroll et al (2015) used similar indicators for 
allostatic load as the present study, allostatic load scores were calculated using a different 
method.  Each physiologic system was assigned a score between 0 and 1 based on the 
proportion of indicators for each system that fell into the highest quartile of risk, then 
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physiologic system scores were summed to compute overall allostatic load (Judith E. 
Carroll et al., 2015).  The authors specify that this method allows for each physiologic 
system to be weighted equally in the total allostatic load score regardless of the number 
of indicators per system (Judith E. Carroll et al., 2015).  The present study does not 
weight each physiologic domain equally and allows for the retention of substantial 
variability from the data.  Another comparison study was identified that studied allostatic 
load in relation to sleep quality.  In that study, serial mediation analyses showed a 
relationship between black race and discrimination, which was then related to the 
experience of anger, which then impacted subjective sleep quality, with then resulted in 
an increased allostatic load (Tomfohr et al., 2016).  Tomfohr et al (2016) calculated 
allostatic load from 11 indicators using methods similar to those of Carroll et al (2015).   
Sleep Duration and Allostatic Load 
Contrary to expectations, there was no relationship between overall allostatic load 
and any operationalization of sleep duration.  Three comparison studies of allostatic load 
and sleep duration were identified.  In contrast to this study’s results, Carroll et al (2015) 
did find a relationship between shorter sleep duration (<5 hours per night) and higher 
allostatic load as well as a relationship between longer sleep duration (>8.5 hours per 
night) and higher allostatic load when compared with normal sleep duration (6.5 to <8.5 
hours of sleep per night).  Chen et al (2014) found a relationship between increased 
allostatic load and short sleep duration (<6 hours per night) but no relationship between 
allostatic load and long sleep duration (9 or more hours per night).  Clark et al (2014) 
found the opposite and showed that short sleep (<6 hours of sleep per night) was not 
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related to allostatic load, but long sleep duration (9 or more hours per night) was 
associated with increased allostatic load.  As with the studies of allostatic load and sleep 
quality, the number of indicators for allostatic load and methods for calculating allostatic 
load differed between the present study and comparison studies.  It is likely that scores 
for allostatic load in the present study differ greatly from the scores for allostatic load 
used by the three comparison studies, potentially explaining the differences in results.   
Sleep Quality and Allostatic Load Physiologic Domains   
Of the individual physiologic system factors, only the HPA factor was associated 
with global sleep quality.  In this study, the direction of the results was unexpected.  Poor 
sleep quality was associated with decreased HPA factor scores, when higher HPA scores 
were hypothesized.  In the CFA model of allostatic load, increased allostatic load is 
indicative of worse physiologic dysfunction.  However, the results of the subjective sleep 
quality and HPA factor analysis shows poor sleep quality to be associated with less 
physiologic dysfunction (better HPA scores).  One possible explanation for these results 
is that the relationship between the HPA factor and sleep quality is nonlinear.  The CFA 
assumes a linear relationship between urinary cortisol and serum DHEAS as they load 
onto the HPA factor and the overall allostatic load factor.  It is possible that the 
relationship between cortisol and DHEAS and the HPA system factor are not linear and 
instead are curvilinear. In a curvilinear relationship, both low and high levels of cortisol 
and DHEAS would be problematic.   A brief check of the literature supports the idea that 
low cortisol and DHEAS could be related to health concerns.  For example, a study of 
adolescent rape survivors with PTSD and matched controls found the rape survivors had 
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significantly lower cortisol and DHEAS levels (Bicanic et al., 2013).  Another study 
found adults reporting high perceived stress at work had a decreased DHEAS response to 
acute stress (Lennartsson, Theorell, Kushnir, Bergquist, & Jonsdottir, 2013).  A study of 
adults with burnout, cortisol, and allostatic load (not including cortisol) found high 
allostatic load and high burnout to be associated with lower cortisol levels (Juster, Sindi, 
et al., 2011).  In the CFA model of allostatic load used in the present study, it seems the 
linear aspect of the relationship between cortisol and DHEAS and the HPA and allostatic 
load factors is driving the factor loadings, while the analysis of the HPA factor on sleep 
quality is hinting at the potential curvilinear aspect of the relationship.  Unfortunately, the 
methods used in this analysis do not allow this to be explored, and these unexpected 
results will need further investigation.  Future investigations of allostatic load should 
investigate the indicators of the HPA system for a curvilinear relationship with allostatic 
load and outcomes of interest.   
Relationship Among Sleep, Allostatic Load, and Future Cancer Occurrence 
It was hypothesized allostatic load would mediate a relationship between future 
cancer occurrence and sleep.  This proved not to be the case.  In models that included all 
three main concepts, sleep, allostatic load, and future cancer, no relationships were found.  
Additionally, analysis results showed that sleep duration, but not subjective sleep quality, 
was associated with future cancer occurrence.  The opposite relationship to sleep 
parameters was found for allostatic load: subjective sleep quality, but no sleep duration, 
was associated with allostatic load.  Based on these results, some aspects of the 
conceptual model of perceived responses to stress were supported and some were not.   
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Nursing Implications 
Sleep is an established important dimension of health.  Sleep has long been 
known to be related to depression, and presence of hypersomnia or insomnia is a criteria 
for a diagnosis of depression (American Psychiatric Association, 2013; Herrick & Sateia, 
2016; Poole & Jackowska, 2017). There is evidence that sleep is related to physical 
health problems as well (Cappuccio et al., 2008, 2010; Cappucio et al., 2010; Ju & Choi, 
2013; Knutson et al., 2009; Lao et al., 2018).  Sleep is both an involuntary activity 
required for human life, as well as a behavior that humans can consciously influence.  
The timing, location, and duration of sleep can be intentionally modified.  Understanding 
of the purpose, function, and activities of sleep is still evolving, but that short and long 
sleep duration are known to be associated with health problems and risk for health 
problems, and this study’s results adds to that body of evidence.  This has implications 
for nursing practice.  From the primary care perspective, it is important to ask about sleep 
as a part of routine health maintenance, and sleep health should be taught to primary care 
nurse practitioners. Typically, medicine is concerned about diagnoses of sleep disorders, 
such as sleep apnea or insomnia, and sleep is only addressed in patient-provider visits if a 
patient reports a sleep related complaint.  Routine sleep guidance is not regularly given to 
adults.  Based on the evidence identified by a review of the literature and the findings of 
this study, sleep, like other lifestyle-related behaviors such as diet, exercise, and smoking, 
should be included in the routine assessment of social history, and questioning patients 
about sleep should be a routine part of health maintenance.  From the acute care 
perspective, sleep is already a component of training to become a registered nurse, but its 
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role as a risk factor for health problems should be emphasized.  Further, in the acute care 
environment, it is important to minimize setting-based disruptions and reductions of 
sleep.   
Limitations 
One of the potentially limiting factors of this study is that due to limitations in the 
data, future cancer of any kind was considered for the outcome.  In contrast, most other 
research studies of cancer and sleep focused on a single type of cancer.  Given the mixed 
findings in the literature about the sleep duration-cancer relationship and the sleep 
quality-cancer relationship, it is possible that the relationship between sleep and future 
cancer occurrence is not the same for all cancers.  Additionally, it is possible that the 
present study included a large proportion of non-melanoma skin cancers.  The study 
sample of 78 cancer cases includes 31 cases that reported having skin cancer, and it is not 
possible to differentiate between melanoma and non-melanoma skin cancer in the data.  
Given that 90% of non-melanoma skin cancers are related to sun exposure, if enough of 
the cancer cases included in this study are due to factors such as sun exposure, it seems 
logical that there would not be a relationship between the future cancer outcome and 
physiologic dysfunction (Skin Cancer Foundation, 2018).  One strategy for addressing 
this issue in the current dataset would be to repeat the analysis using a case-control 
sample using only non-skin cancer cases and matched controls.  Future studies should 
consider using a larger sample of cancer cases and examining the sleep-cancer 
relationship with both any cancer and specific cancer types.   
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 Another limitation of this study is the number of years between assessments.  The 
years between time 1 (assessment of allostatic load and sleep) and time 2 (assessment of 
cancer status) in the study ranged 3-9 years.  It is possible the induction and latent periods 
of cancer in relation to sleep quality and allostatic load are longer than 3 to 9 years, and 
longer-term follow up is required to identify relationships.   
Future Research Directions 
In future research endeavors exploring the relationships between cognitive-
behavioral responses to stress, physiologic responses to stress, and disease, care should 
be taken to carefully conceptualize and operationalize the phenomena at work.  For 
example, measures of future cancer, a disease, need to be carefully selected, and cases of 
non-melanoma skin cancer should perhaps be examined separately. In addition to cancer, 
other chronic diseases have become epidemic in the US (Centers for Disease Control and 
Prevention, 2017c).  Although the results of this study do not support the full conceptual 
framework, it may prove to be an appropriate framework for studying other disease 
outcomes.  It may worth repeating this project with a different outcome, such as heart 
disease or diabetes, to examine for relationships between sleep parameters, allostatic 
load, and disease.  
Future research should examine the best measurement of sleep quality.  While the 
PSQI is established as a reliable and valid measure of sleep quality, the results of the 
present study identify one flaw in the PSQI.  The PSQI considers any sleep duration of 7 
hours or more to be normal, and it does not consider the possibility that long sleep 
duration could be problematic.  As demonstrated in the findings of this study, it is likely 
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that sleep duration is similar to caloric intake in that health problems can occur if it is 
either too small or too large.   
Research investigating the purpose and function of sleep, the parameters of sleep 
related to health, and how sleep can impact health and disease is evolving and our 
understanding of the sleep-health relationship is emerging.  The existing evidence of 
sleep duration and future cancer is mixed.  No studies were identified by a review of the 
literature that examined their data for relevant categories of sleep duration.  Future 
research should continue to explore populations for significant categories of sleep 
duration in relation to disease occurrence.  As research progresses, parameters of sleep 
may be identified that are more meaningful to health and disease development than sleep 
duration.  For example, research of circadian disruption and risk for cancer is showing 
some promise (Cordina-Duverger et al., 2018).  
In future studies, indicators of allostatic load should be thoughtfully selected for 
inclusion, and relevant measures of selected indicators utilized.  Conceptually, allostatic 
load is a measure of cumulative multi-system physiologic dysfunction.  Typically in 
studies of allostatic load, baseline resting catecholamines and cortisol are measured and 
used to comprise allostatic load, and these measures were used in this study.  However, 
perhaps these baseline values are not as relevant as measures of the acute stress response.  
The conceptual framework assumes a cumulative build-up of physiologic dysfunction in 
response to stress, and maybe baseline values do not capture that dysfunction as well as 
stress test measures.  Perhaps physiologic response to stress, a main concept in this study, 
could be captured better if it was measured in acute stress situations.  
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The methods for capturing the HPA domain of allostatic load need further 
investigation.  The CFA assumes a linear relationship between urinary cortisol and serum 
DHEAS as they load onto the HPA factor and the overall allostatic load factor.  The 
results of the present study indicate the relationship between cortisol and DHEAS and the 
HPA axis domain are not linear and instead are curvilinear. In a curvilinear relationship, 
both low and high levels of cortisol and DHEAS would be problematic.   Future studies 
of allostatic load should consider exploring the possibility of cortisol and DHEAS having 
a curvilinear relationship with allostatic load.   
Conclusions 
Cognitive-behavioral responses to stress, physical activity, smoking, and alcohol 
use, have become critical to the management and prevention of chronic disease (Centers 
for Disease Control and Prevention, 2017c).  The results of this study indicate sleep may 
play a similar role for cancer.  Although further research is needed, the results of this 
study’s analysis of sleep duration and future cancer seem to indicate the National Sleep 
Foundation’s recommendations for healthy sleep duration may not be appropriate in 
relation to developing a cancer in the future.   
This study was developed based on a conceptual framework of responses to stress 
that connects sleep, allostatic load and future cancer.  The results show that sleep 
parameters related to subjective sleep quality are not related to future cancer, but certain 
parameters of sleep duration are associated with future cancer.  Next, the results show 
that allostatic load is not related to future cancer.  Finally, the results show allostatic load 
and subjective sleep quality are related, but allostatic load and sleep duration are not.  
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Given these findings, it seems that sleep and cancer and, separately, sleep and allostatic 
load are likely operating on different pathways, but the results are not definitive.  
Potential relationships between sleep parameters, allostatic load, and future cancer need 
further exploration.  
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